0001193125-13-010283.txt : 20130111 0001193125-13-010283.hdr.sgml : 20130111 20130111102019 ACCESSION NUMBER: 0001193125-13-010283 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20130111 DATE AS OF CHANGE: 20130111 EFFECTIVENESS DATE: 20130111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MET INVESTORS SERIES TRUST CENTRAL INDEX KEY: 0001126087 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 333-48456 FILM NUMBER: 13524446 BUSINESS ADDRESS: STREET 1: 610 NEWPORT CENTER DRIVE STE 1350 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 BUSINESS PHONE: 8008483854 MAIL ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1900 CITY: IRVINE STATE: CA ZIP: 92614 0001126087 S000021940 Met/Templeton Growth Portfolio C000063048 Class B C000063050 Class E C000063051 Class A 497 1 d457708d497.htm MET INVESTORS SERIES TRUST - MET/TEMPLETON GROWTH SUPP Met Investors Series Trust - Met/Templeton Growth Supp
    Sullivan & Worcester LLP   T 202 775 1200
    1666 K Street, NW   F 202 293 2275
    Washington, DC 20006   www.sandw.com

 

January 11, 2013

 

VIA EDGAR

 

EDGAR Operations Branch

Division of Investment Management

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

  Re:   Met Investors Series Trust (the “Trust”)
    SEC File Nos. 333-48456, 811-10183
    CIK - 0001126087

 

Ladies and Gentlemen:

 

Pursuant to Rule 497 under the Securities Act of 1933, as amended, enclosed is the Interactive Data File that mirrors the risk/return summary information in the supplement dated December 20, 2012 to the prospectus dated April 30, 2012 for the Met/Templeton Growth Portfolio, a series of the Trust, filed under Rule 497(e) on December 20, 2012 (SEC Accession No. 0001193125-12-510005).

 

Any questions or comments with respect to this filing may be directed to the undersigned at (202) 775-1213.

 

Very truly yours,
 /s/ John L. Chilton

 

Enclosures

 

cc: Andrew L. Gangolf, Esq.
  Michael P. Lawlor, Esq.
  David C. Mahaffey, Esq.
EX-101.INS 2 mist6-20121220.xml XBRL INSTANCE DOCUMENT 0001126087 2011-05-01 2012-04-30 0001126087 mist6:S000021940Member 2011-05-01 2012-04-30 2012-04-30 Other MET INVESTORS SERIES TRUST 0001126087 2012-12-20 2012-12-20 2011-12-31 false <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>MET INVESTORS SERIES TRUST </b></font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>SUPPLEMENT DATED DECEMBER 20, 2012 </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>TO THE </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>PROSPECTUS DATED APRIL 30, 2012 </b></font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>MET/TEMPLETON GROWTH PORTFOLIO </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">The Board of Trustees of Met Investors Series Trust (the &#147;Trust&#148;) has approved a change of subadviser for the Met/Templeton Growth Portfolio (the &#147;Portfolio&#148;) from Templeton Global Advisors Limited (&#147;Templeton&#148;) to OppenheimerFunds, Inc. (&#147;Oppenheimer&#148;) to be effective April&nbsp;29, 2013, pursuant to a new subadvisory agreement between the Trust&#146;s investment adviser, MetLife Advisers, LLC, and Oppenheimer. Effective April&nbsp;29, 2013, the name of the Portfolio will change to Oppenheimer Global Equity Portfolio, and, unless noted otherwise below, all references to the former name of the Portfolio contained in the Prospectus will change to the Portfolio&#146;s new name and references in the Portfolio&#146;s Prospectus to Templeton will change to Oppenheimer. The Insurance Companies (as defined in the Prospectus) may temporarily continue to refer to Templeton and to the Portfolio by its original name in their forms and communications until such documents can be revised. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In connection with the changes described above, the following changes to the Portfolio&#146;s Prospectus are effective April&nbsp;29, 2013: </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the disclosure in the section entitled &#147;Investment Objective&#148; is deleted in its entirety and replaced with the following: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Capital appreciation. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the disclosure in the footnote in the section entitled &#147;Annual Portfolio Operating Expenses&#148; is deleted in its entirety and replaced with the following: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">* MetLife Advisers, LLC has contractually agreed, for the period April&nbsp;29, 2013 through April&nbsp;30, 2014, to reduce the management fee for each Class of the Portfolio to the annual rate of 0.630% for amounts over $462.5 million but less than $550 million of the Portfolio&#146;s average daily net assets, 0.590% for the next $500 million of the Portfolio&#146;s average daily net assets, and 0.565% for amounts over $1.05 billion. This arrangement may be modified or discontinued prior to April&nbsp;30, 2014, only with the approval of the Board of Trustees of the Portfolio. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the section entitled &#147;Principal Investment Strategies&#148; is deleted in its entirety and replaced with the following: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">OppenheimerFunds, Inc. (&#147;Oppenheimer&#148;), subadviser to the Portfolio, invests under normal circumstances at least 80% of the Portfolio&#146;s assets in equity securities (primarily common stock) of U.S. and foreign-based companies. Equity securities also include preferred stocks and securities convertible into common or preferred stocks. The Portfolio can invest without limit in foreign securities and can invest in any country, including countries with developed or emerging markets. However, the Portfolio currently emphasizes its investments in developed markets such as the United States, Western European countries and Japan. The Portfolio does not limit its investments to companies in a particular capitalization range, but currently focuses its investments in mid- and large-cap companies. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">The Portfolio is not required to allocate its investments in any set percentages in any particular country. The Portfolio normally will invest in at least three countries (one of which may be the United States). Typically, the Portfolio invests in a number of different countries. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">The Portfolio may also invest in derivatives, forward commitments, and when-issued and delayed delivery securities. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Stock Selection </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">In selecting securities for the Portfolio, Oppenheimer looks primarily for foreign and U.S. companies with high growth potential. Oppenheimer uses fundamental analysis of a company&#146;s financial statements, management structure, operations and product development, and industry position. Oppenheimer evaluates factors affecting particular industries, market trends and general economic conditions. </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Oppenheimer considers overall and relative economic conditions in U.S. and foreign markets, and seeks broad portfolio diversification in different countries to help moderate the special risks of foreign investing. Oppenheimer currently focuses on the factors below (which may vary in particular cases and may change over time), looking for: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Growth oriented companies. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Companies that stand to benefit from global growth trends at attractive valuations. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Companies with strong competitive positions and high demand for their products or services. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Cyclical opportunities in the business cycle and sectors or industries that may benefit from those opportunities. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">In applying these and other selection criteria, Oppenheimer considers the effect of worldwide trends on the growth of various business sectors. The trends, or global &#147;themes,&#148; currently considered include development of new technologies, corporate restructuring, the growth of mass affluence and demographic changes. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, &#147;Credit and Counterparty Risk,&#148; &#147;Interest Rate Risk,&#148; and &#147;Focused Investment Risk&#148; are deleted in their entirety from the section entitled &#147;Primary Risks&#148; and the following disclosures are added at the end of that section: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3"><b>Derivatives Risk.</b> The Portfolio may invest in derivatives to obtain investment exposure, enhance return or &#147;hedge&#148; or protect its assets from an unfavorable shift in the value or rate of a reference instrument. Derivatives can significantly increase the Portfolio&#146;s exposure to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy) and other risks. Derivatives may be illiquid and difficult to value. Because of their complex nature, some derivatives may not perform as intended. As a result, the Portfolio may not realize the anticipated benefits from a derivative it holds or it may realize losses. Derivative transactions may create investment leverage, which may increase the Portfolio&#146;s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3"><b>Convertible Securities Risk.</b> Investments in convertible securities may be subject to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy), interest rate risk (the risk that the value of an investment in an income-producing security will decrease as interest rates rise) and other risks associated with investments in equity and fixed income securities, depending on the price of the underlying security and the conversion price. In addition, a convertible security may be bought back by the issuer at a time and a price that is disadvantageous to the Portfolio. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3"><b>Forward Commitment, When-Issued and Delayed Delivery Securities Risk.</b> Investments in forward commitments and when-issued and delayed delivery securities are subject to the risk that the value or yield of the securities the Portfolio is obligated to purchase may decline below the agreed upon purchase price or expected yield before the securities are actually issued or delivered. These investments may create a form of investment leverage, which may increase the Portfolio&#146;s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the following disclosure is added at the end of the first paragraph in the section entitled &#147;Past Performance&#148;: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Effective April&nbsp;29, 2013, Oppenheimer became the subadviser to the Portfolio, and the Portfolio changed its investment objective and principal investment strategies. Performance information set forth below does not reflect any of these changes. Investment performance prior to that date is attributable to the Portfolio&#146;s former investment subadviser. </font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>MET INVESTORS SERIES TRUST </b></font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>SUPPLEMENT DATED DECEMBER 20, 2012 </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>TO THE </b></font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>PROSPECTUS DATED APRIL 30, 2012 </b></font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px" align="center"><font style="font-family:times new roman" size="3"><b>MET/TEMPLETON GROWTH PORTFOLIO </b></font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">The Board of Trustees of Met Investors Series Trust (the &#147;Trust&#148;) has approved a change of subadviser for the Met/Templeton Growth Portfolio (the &#147;Portfolio&#148;) from Templeton Global Advisors Limited (&#147;Templeton&#148;) to OppenheimerFunds, Inc. (&#147;Oppenheimer&#148;) to be effective April&nbsp;29, 2013, pursuant to a new subadvisory agreement between the Trust&#146;s investment adviser, MetLife Advisers, LLC, and Oppenheimer. Effective April&nbsp;29, 2013, the name of the Portfolio will change to Oppenheimer Global Equity Portfolio, and, unless noted otherwise below, all references to the former name of the Portfolio contained in the Prospectus will change to the Portfolio&#146;s new name and references in the Portfolio&#146;s Prospectus to Templeton will change to Oppenheimer. The Insurance Companies (as defined in the Prospectus) may temporarily continue to refer to Templeton and to the Portfolio by its original name in their forms and communications until such documents can be revised. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In connection with the changes described above, the following changes to the Portfolio&#146;s Prospectus are effective April&nbsp;29, 2013: </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the disclosure in the section entitled &#147;Investment Objective&#148; is deleted in its entirety and replaced with the following: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Capital appreciation. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the disclosure in the footnote in the section entitled &#147;Annual Portfolio Operating Expenses&#148; is deleted in its entirety and replaced with the following: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">* MetLife Advisers, LLC has contractually agreed, for the period April&nbsp;29, 2013 through April&nbsp;30, 2014, to reduce the management fee for each Class of the Portfolio to the annual rate of 0.630% for amounts over $462.5 million but less than $550 million of the Portfolio&#146;s average daily net assets, 0.590% for the next $500 million of the Portfolio&#146;s average daily net assets, and 0.565% for amounts over $1.05 billion. This arrangement may be modified or discontinued prior to April&nbsp;30, 2014, only with the approval of the Board of Trustees of the Portfolio. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the section entitled &#147;Principal Investment Strategies&#148; is deleted in its entirety and replaced with the following: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">OppenheimerFunds, Inc. (&#147;Oppenheimer&#148;), subadviser to the Portfolio, invests under normal circumstances at least 80% of the Portfolio&#146;s assets in equity securities (primarily common stock) of U.S. and foreign-based companies. Equity securities also include preferred stocks and securities convertible into common or preferred stocks. The Portfolio can invest without limit in foreign securities and can invest in any country, including countries with developed or emerging markets. However, the Portfolio currently emphasizes its investments in developed markets such as the United States, Western European countries and Japan. The Portfolio does not limit its investments to companies in a particular capitalization range, but currently focuses its investments in mid- and large-cap companies. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">The Portfolio is not required to allocate its investments in any set percentages in any particular country. The Portfolio normally will invest in at least three countries (one of which may be the United States). Typically, the Portfolio invests in a number of different countries. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">The Portfolio may also invest in derivatives, forward commitments, and when-issued and delayed delivery securities. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Stock Selection </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">In selecting securities for the Portfolio, Oppenheimer looks primarily for foreign and U.S. companies with high growth potential. Oppenheimer uses fundamental analysis of a company&#146;s financial statements, management structure, operations and product development, and industry position. Oppenheimer evaluates factors affecting particular industries, market trends and general economic conditions. </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Oppenheimer considers overall and relative economic conditions in U.S. and foreign markets, and seeks broad portfolio diversification in different countries to help moderate the special risks of foreign investing. Oppenheimer currently focuses on the factors below (which may vary in particular cases and may change over time), looking for: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Growth oriented companies. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Companies that stand to benefit from global growth trends at attractive valuations. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Companies with strong competitive positions and high demand for their products or services. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <table style="border-collapse:collapse" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="10%"><font size="1">&nbsp;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="3"><font style="font-family:times new roman" size="3">&#149;</font><font style="font-family:times new roman" size="3"></font></font></td> <td width="1%" valign="top">&nbsp;</td> <td align="left" valign="top"><font style="font-family:times new roman" size="3">Cyclical opportunities in the business cycle and sectors or industries that may benefit from those opportunities. </font></td></tr></table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">In applying these and other selection criteria, Oppenheimer considers the effect of worldwide trends on the growth of various business sectors. The trends, or global &#147;themes,&#148; currently considered include development of new technologies, corporate restructuring, the growth of mass affluence and demographic changes. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, &#147;Credit and Counterparty Risk,&#148; &#147;Interest Rate Risk,&#148; and &#147;Focused Investment Risk&#148; are deleted in their entirety from the section entitled &#147;Primary Risks&#148; and the following disclosures are added at the end of that section: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3"><b>Derivatives Risk.</b> The Portfolio may invest in derivatives to obtain investment exposure, enhance return or &#147;hedge&#148; or protect its assets from an unfavorable shift in the value or rate of a reference instrument. Derivatives can significantly increase the Portfolio&#146;s exposure to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy) and other risks. Derivatives may be illiquid and difficult to value. Because of their complex nature, some derivatives may not perform as intended. As a result, the Portfolio may not realize the anticipated benefits from a derivative it holds or it may realize losses. Derivative transactions may create investment leverage, which may increase the Portfolio&#146;s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3"><b>Convertible Securities Risk.</b> Investments in convertible securities may be subject to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy), interest rate risk (the risk that the value of an investment in an income-producing security will decrease as interest rates rise) and other risks associated with investments in equity and fixed income securities, depending on the price of the underlying security and the conversion price. In addition, a convertible security may be bought back by the issuer at a time and a price that is disadvantageous to the Portfolio. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3"><b>Forward Commitment, When-Issued and Delayed Delivery Securities Risk.</b> Investments in forward commitments and when-issued and delayed delivery securities are subject to the risk that the value or yield of the securities the Portfolio is obligated to purchase may decline below the agreed upon purchase price or expected yield before the securities are actually issued or delivered. These investments may create a form of investment leverage, which may increase the Portfolio&#146;s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="3">In the Portfolio Summary, the following disclosure is added at the end of the first paragraph in the section entitled &#147;Past Performance&#148;: </font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&nbsp;</font></p> <p style="margin-top:0px;margin-bottom:0px; margin-left:5%"><font style="font-family:times new roman" size="3">Effective April&nbsp;29, 2013, Oppenheimer became the subadviser to the Portfolio, and the Portfolio changed its investment objective and principal investment strategies. Performance information set forth below does not reflect any of these changes. Investment performance prior to that date is attributable to the Portfolio&#146;s former investment subadviser. </font></p> EX-101.SCH 3 mist6-20121220.xsd XBRL TAXONOMY EXTENSION SCHEMA 000000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 000010 - Document - Risk/Return Supplement {Unlabeled} - Met/Templeton Growth Portfolio link:presentationLink link:calculationLink link:definitionLink 000011 - Document - Risk/Return Summary {Unlabeled} - Met/Templeton Growth Portfolio link:presentationLink link:calculationLink link:definitionLink 000012 - Schedule - Shareholder Fees {- Met/Templeton Growth Portfolio} link:presentationLink link:calculationLink link:definitionLink 000013 - Schedule - Annual Fund Operating Expenses {- Met/Templeton Growth Portfolio} link:presentationLink link:calculationLink link:definitionLink 000014 - Schedule - Expense Example {Transposed} {- Met/Templeton Growth Portfolio} link:presentationLink link:calculationLink link:definitionLink 000015 - Schedule - Expense Example, No Redemption {Transposed} {- Met/Templeton Growth Portfolio} link:presentationLink link:calculationLink link:definitionLink 000016 - Schedule - Annual Total Returns - Met/Templeton Growth Portfolio [BarChart] link:presentationLink link:calculationLink link:definitionLink 000017 - Schedule - Average Annual Total Returns {Transposed} {- Met/Templeton Growth Portfolio} link:presentationLink link:calculationLink link:definitionLink 000018 - Document - Risk/Return Detail {Unlabeled} - Met/Templeton Growth Portfolio link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - Risk/Return Detail Data {Elements} - Met/Templeton Growth Portfolio link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 mist6-20121220_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 5 mist6-20121220_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 6 mist6-20121220_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 7 mist6-20121220_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } EXCEL 9 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P931B9F-B8E]C8F9B7S1D-C9?865D.5]A960Q M,V1A9C0W9C$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O M=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D M/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D M('=I=&@@36EC'1087)T7S!E-&)F8V)B7V-B M9F)?-&0V-E]A960Y7V%E9#$S9&%F-#=F,0T*0V]N=&5N="U,;V-A=&EO;CH@ M9FEL93HO+R]#.B\P931B9F-B8E]C8F9B7S1D-C9?865D.5]A960Q,V1A9C0W M9C$O5V]R:W-H965T'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^3454($E.5D535$]24R!315))15,@5%)54U0\'0^9F%L'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'`@#MM87)G M:6XM8F]T=&]M.C!P>"!A;&EG;CTS1&-E;G1E3IT:6UEF4],T0S/CQB/DU%5"!) M3E9%4U1/4E,@4T522453(%1255-4(#PO8CX\+V9O;G0^/"]P/B`\<"!S='EL M93TS1&UA#X\9F]N="!S M:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@#MM87)G:6XM M8F]T=&]M.C!P>"!A;&EG;CTS1&-E;G1E3IT:6UEF4],T0S/CQB/E1/(%1(12`\ M+V(^/"]F;VYT/CPO<#X@/'`@#MM87)G M:6XM8F]T=&]M.C!P>"!A;&EG;CTS1&-E;G1E3IT:6UEF4],T0S/CQB/E!23U-0 M14-455,@1$%4140@05!224P@,S`L(#(P,3(@/"]B/CPO9F]N=#X\+W`^(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF M;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$;6%R M9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@@86QI9VX],T1C96YT97(^ M/&9O;G0@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN M+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M.C!P>#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0S/E1H92!";V%R9"!O9B!42!A9W)E96UE;G0@8F5T=V5E;B!T:&4@5')U2!T96UP;W)A2!C;VYT:6YU M92!T;R!R969EF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^ M(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^ M/&9O;G0@6QE/3-$;6%R9VEN+71O M<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM M8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0S/DEN('1H92!0;W)T9F]L:6\@4W5M;6%R>2P@ M=&AE(&1I#MM87)G:6XM8F]T M=&]M.BTV<'@^/&9O;G0@3IT:6UE MF4],T0S/D-A<&ET86P@87!PF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O M;G0@'!E;G-E2!A;F0@#X\9F]N="!S:7IE/3-$,3XF;F)S M<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G M:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0@)#4P,"!M:6QL:6]N(&]F('1H92!0;W)T9F]L:6\F(S$T M-CMS(&%V97)A9V4@9&%I;'D@;F5T(&%SF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE M/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M.BTV<'@^/&9O;G0@3IT:6UEF4],T0S/D]P<&5N M:&5I;65R1G5N9',L($EN8RX@*"8C,30W.T]P<&5N:&5I;65R)B,Q-#@[*2P@ M2!C;VUM;VX@F%T:6]N(')A;F=E+"!B=70@8W5R6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O M;3HP<'@^/&9O;G0@3IT:6UEF4],T0S/E1H92!0;W)T9F]L:6\@:7,@;F]T(')E<75I M2!P87)T:6-U;&%R(&-O=6YT#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N M="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G M:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M2!S96-UF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$ M)VUA#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N M="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G M:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M2!F;W(@9F]R96EG M;B!A;F0@52Y3+B!C;VUP86YI97,@=VET:"!H:6=H(&=R;W=T:"!P;W1E;G1I M86PN($]P<&5N:&5I;65R('5S97,@9G5N9&%M96YT86P@86YA;'ES:7,@;V8@ M82!C;VUP86YY)B,Q-#8[2!P;W-I=&EO;BX@3W!P96YH96EM97(@979A M;'5A=&5S(&9A8W1O#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^ M/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!F;V-U M2!I;B!P M87)T:6-U;&%R(&-A#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\ M+V9O;G0^/"]P/B`\=&%B;&4@F4],T0S/B8C,30Y M.SPO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0S/CPO9F]N=#X\+V9O;G0^/"]T9#X@/'1D('=I9'1H M/3-$,24@=F%L:6=N/3-$=&]P/B9N8G-P.SPO=&0^(#QT9"!A;&EG;CTS1&QE M9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@#X\9F]N="!S:7IE/3-$ M,3XF;F)S<#L\+V9O;G0^/"]P/B`\=&%B;&4@F4] M,T0S/B8C,30Y.SPO9F]N=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0S/CPO9F]N=#X\+V9O;G0^/"]T9#X@ M/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$=&]P/B9N8G-P.SPO=&0^(#QT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\=&%B M;&4@F4],T0S/B8C,30Y.SPO9F]N=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0S M/CPO9F]N=#X\+V9O;G0^/"]T9#X@/'1D('=I9'1H/3-$,24@=F%L:6=N/3-$ M=&]P/B9N8G-P.SPO=&0^(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE M/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I M>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`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`\+V9O;G0^/"]P M/B`\<"!S='EL93TS1&UAF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$ M)VUA2!B92!S=6)J96-T('1O(&UA2!R:7-K("AT:&4@2DL(&EN=&5R97-T(')A=&4@6QE M/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@3IT:6UEF4] M,T0S/CQB/D9O6EE;&0@8F5F;W)E('1H92!S96-U2!I2!A;F0@;6%Y(')E<75I#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S:7IE M/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O M='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP M('-T>6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P931B9F-B8E]C8F9B M7S1D-C9?865D.5]A960Q,V1A9C0W9C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,&4T8F9C8F)?8V)F8E\T9#8V7V%E9#E?865D,3-D868T-V8Q M+U=O'0O M:'1M;#L@8VAA5)E9VES=')A;G1.86UE/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#Y-150@24Y615-43U)3(%-%4DE%4R!44E535#QS<&%N M/CPO6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R M9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\ M+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP M<'@@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@#MM87)G:6XM8F]T=&]M.BTV<'@^/&9O;G0@#MM87)G:6XM8F]T M=&]M.C!P>"!A;&EG;CTS1&-E;G1E3IT:6UEF4],T0S/CQB/DU%5"]414U03$54 M3TX@1U)/5U1((%!/4E1&3TQ)3R`\+V(^/"]F;VYT/CPO<#X@/'`@#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S:7IE M/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!0 M;W)T9F]L:6\L(&%N9"P@=6YL97-S(&YO=&5D(&]T:&5R=VES92!B96QO=RP@ M86QL(')E9F5R96YC97,@=&\@=&AE(&9O2!I=',@;W)I9VEN86P@;F%M92!I M;B!T:&5I6QE M/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0S/DEN(&-O;FYE8W1I;VX@ M=VET:"!T:&4@8VAA;F=E#MM87)G:6XM8F]T=&]M.C!P M>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS M1&UA6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!A;F0@#X\9F]N="!S:7IE/3-$ M,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P M>#MM87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$ M;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0S/DEN('1H92!0;W)T9F]L:6\@ M4W5M;6%R>2P@=&AE(&1I6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM M-G!X/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE M/3-$)VUA6QE/3-$;6%R9VEN M+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G M:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0S/DEN('1H92!0;W)T9F]L:6\@4W5M;6%R M>2P@=&AE('-E8W1I;VX@96YT:71L960@)B,Q-#<[4')I;F-I<&%L($EN=F5S M=&UE;G0@4W1R871E9VEE2!A;F0@#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL M93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN M+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@2!S96-U M2P@:6YC;'5D:6YG(&-O=6YT2!E;7!H87-I>F5S(&ET#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF M;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM M87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!S970@<&5R8V5N=&%G97,@:6X@86YY('!A2X@5&AE(%!O2!W:6QL(&EN M=F5S="!I;B!A="!L96%S="!T:')E92!C;W5N=')I97,@*&]N92!O9B!W:&EC M:"!M87D@8F4@=&AE(%5N:71E9"!3=&%T97,I+B!4>7!I8V%L;'DL('1H92!0 M;W)T9F]L:6\@:6YV97-TF4],T0Q/B9N8G-P.SPO9F]N M=#X\+W`^(#QP('-T>6QE/3-$)VUA2!A;'-O(&EN=F5S="!I;B!D97)I=F%T:79E65D(&1E;&EV97)Y M('-E8W5R:71I97,N(#PO9F]N=#X\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O M<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@3IT:6UEF4],T0S/E-T;V-K(%-E M;&5C=&EO;B`\+V9O;G0^/"]P/B`\<"!S='EL93TS1&UAF4],T0Q/B9N8G-P.SPO9F]N M=#X\+W`^(#QP('-T>6QE/3-$)VUA7-I6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT M('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)VUA2!V87)Y(&EN('!A2!C:&%N9V4@;W9E6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X M/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QT86)L92!S='EL M93TS1&)O3IT:6UEF4],T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O M='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QT M86)L92!S='EL93TS1&)O3IT:6UEF4],T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R M9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q M/B9N8G-P.SPO9F]N=#X\+W`^(#QT86)L92!S='EL93TS1&)O3IT:6UEF4],T0S/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@#MM87)G M:6XM8F]T=&]M.BTV<'@^/&9O;G0@6QE/3-$8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E(&)O MF4],T0Q M/B9N8G-P.SPO9F]N=#X\+W1D/B`\=&0@=VED=&@],T0R)2!V86QI9VX],T1T M;W`@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0S/D-Y8VQI8V%L(&]P<&]R='5N:71I97,@:6X@=&AE M(&)U#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O M;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T M=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@#MM87)G:6XM M8F]T=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\ M<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!2:7-K+"8C,30X.R`F(S$T-SM);G1E2!F#X\9F]N="!S M:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM M=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!N;W0@<&5R9F]R;2!A6QE/3-$;6%R9VEN+71O M<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@3IT:6UEF4],T0S/CQB/D-O;G9E M2!A;F0@9FEX960@ M:6YC;VUE('-E8W5R:71I97,L(&1E<&5N9&EN9R!O;B!T:&4@<')I8V4@;V8@ M=&AE('5N9&5R;'EI;F<@2!M87D@ M8F4@8F]U9VAT(&)A8VL@8GD@=&AE(&ES#MM87)G M:6XM8F]T=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P M/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P M>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@2!396-U2!S96-U M2!D96-L:6YE(&)E;&]W('1H92!A M9W)E960@=7!O;B!P=7)C:&%S92!P'!E8W1E9"!Y:65L9"!B M969O2!C2!I;F-R96%S92!T M:&4@4&]R=&9O;&EO)B,Q-#8[2!N;W0@8F4@861V86YT86=E;W5S('1O(&1O('-O M+B`\+V9O;G0^/"]P/B`\<"!S='EL93TS1&UAF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^ M(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^ M/&9O;G0@#MM87)G:6XM8F]T=&]M.BTV<'@^/&9O;G0@F4],T0S M/D5F9F5C=&EV92!!<')I;"9N8G-P.S(Y+"`R,#$S+"!/<'!E;FAE:6UE2!O9B!T:&5S92!C:&%N9V5S+B!);G9E6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O M;3HM-G!X/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T M>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@#MM87)G:6XM M8F]T=&]M.BTV<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M.C!P>"!A M;&EG;CTS1&-E;G1E3IT:6UE MF4],T0S/CQB/DU%5"]414U03$543TX@1U)/5U1( M(%!/4E1&3TQ)3R`\+V(^/"]F;VYT/CPO<#X@/'`@#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF;F)S M<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@2!0;W)T9F]L:6\L M(&%N9"P@=6YL97-S(&YO=&5D(&]T:&5R=VES92!B96QO=RP@86QL(')E9F5R M96YC97,@=&\@=&AE(&9O2!I=',@;W)I9VEN86P@;F%M92!I;B!T:&5I6QE/3-$;6%R9VEN M+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G M:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0S/DEN(&-O;FYE8W1I;VX@=VET:"!T:&4@ M8VAA;F=E#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S M:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!A;F0@#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\ M+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM M8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O M<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM M8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0S/DEN('1H92!0;W)T9F]L:6\@4W5M;6%R>2P@ M=&AE(&1I6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT M('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)VUA6QE/3-$;6%R9VEN+71O<#HP<'@[ M;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0S/DEN('1H92!0;W)T9F]L:6\@4W5M;6%R>2P@=&AE('-E M8W1I;VX@96YT:71L960@)B,Q-#<[4')I;F-I<&%L($EN=F5S=&UE;G0@4W1R M871E9VEE2!A;F0@ M#X\9F]N M="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G M:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M2!S96-U2P@ M:6YC;'5D:6YG(&-O=6YT2!E M;7!H87-I>F5S(&ET#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O M;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T M=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!S970@<&5R8V5N=&%G97,@:6X@86YY('!A2X@5&AE(%!O2!W:6QL(&EN=F5S="!I;B!A M="!L96%S="!T:')E92!C;W5N=')I97,@*&]N92!O9B!W:&EC:"!M87D@8F4@ M=&AE(%5N:71E9"!3=&%T97,I+B!4>7!I8V%L;'DL('1H92!0;W)T9F]L:6\@ M:6YV97-TF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP M('-T>6QE/3-$)VUA2!A;'-O M(&EN=F5S="!I;B!D97)I=F%T:79E65D(&1E;&EV97)Y('-E8W5R:71I M97,N(#PO9F]N=#X\+W`^(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R M9VEN+6)O='1O;3HP<'@^/&9O;G0@3IT:6UEF4],T0S/E-T;V-K(%-E;&5C=&EO;B`\ M+V9O;G0^/"]P/B`\<"!S='EL93TS1&UAF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP M('-T>6QE/3-$)VUA7-I6QE/3-$;6%R M9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q M/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)VUA2!V87)Y(&EN('!A2!C:&%N9V4@ M;W9E6QE M/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I M>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QT86)L92!S='EL93TS1&)OF4],T0S M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X M/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QT86)L92!S='EL M93TS1&)O3IT:6UEF4],T0S/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O<#HP M<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q/B9N8G-P.SPO M9F]N=#X\+W`^(#QT86)L92!S='EL93TS1&)O3IT:6UEF4],T0S/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@#MM87)G:6XM8F]T=&]M M.BTV<'@^/&9O;G0@6QE/3-$8F]R9&5R+6-O;&QA<'-E.F-O;&QA<'-E(&)OF4],T0Q/B9N8G-P.SPO M9F]N=#X\+W1D/B`\=&0@=VED=&@],T0R)2!V86QI9VX],T1T;W`@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0S/D-Y8VQI8V%L(&]P<&]R='5N:71I97,@:6X@=&AE(&)U#MM87)G:6XM M8F]T=&]M.C!P>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\ M<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#L@ M;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@#MM87)G:6XM8F]T=&]M.C!P M>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS M1&UA6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!2:7-K+"8C,30X.R`F(S$T-SM);G1E2!F#X\9F]N="!S:7IE/3-$,3XF M;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P>#MM M87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN+6QE9G0Z-24G/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'!O2!N;W0@<&5R9F]R;2!A2!C M6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R M9VEN+6)O='1O;3HP<'@^/&9O;G0@3IT:6UEF4],T0S/CQB/D-O;G9E2!A;F0@9FEX960@:6YC;VUE('-E M8W5R:71I97,L(&1E<&5N9&EN9R!O;B!T:&4@<')I8V4@;V8@=&AE('5N9&5R M;'EI;F<@2!M87D@8F4@8F]U9VAT M(&)A8VL@8GD@=&AE(&ES#MM87)G:6XM8F]T=&]M M.C!P>#X\9F]N="!S:7IE/3-$,3XF;F)S<#L\+V9O;G0^/"]P/B`\<"!S='EL M93TS1"=M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#L@;6%R9VEN M+6QE9G0Z-24G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@2!396-U2!S96-U2!D96-L:6YE(&)E;&]W('1H92!A9W)E960@=7!O M;B!P=7)C:&%S92!P'!E8W1E9"!Y:65L9"!B969O2!I;F-R96%S92!T:&4@4&]R=&9O M;&EO)B,Q-#8[2!N;W0@8F4@861V86YT86=E;W5S('1O(&1O('-O+B`\+V9O;G0^ M/"]P/B`\<"!S='EL93TS1&UAF4],T0Q/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE M/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M.BTV<'@^/&9O;G0@3IT:6UEF4],T0S/D5F9F5C=&EV M92!!<')I;"9N8G-P.S(Y+"`R,#$S+"!/<'!E;FAE:6UE2!O M9B!T:&5S92!C:&%N9V5S+B!);G9E'1087)T M7S!E-&)F8V)B7V-B9F)?-&0V-E]A960Y7V%E9#$S9&%F-#=F,0T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P931B9F-B8E]C8F9B7S1D-C9?865D M.5]A960Q,V1A9C0W9C$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA5)E9VES=')A;G1.86UE/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y-150@24Y615-43U)3(%-%4DE% M4R!44E535#QS<&%N/CPO'0^1&5C(#(P+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\P931B9F-B8E]C8F9B7S1D-C9?865D.5]A960Q,V1A M9C0W9C$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,&4T8F9C8F)? M8V)F8E\T9#8V7V%E9#E?865D,3-D868T-V8Q+U=O&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I M;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U&UL/@T*+2TM+2TM/5].97AT4&%R J=%\P931B9F-B8E]C8F9B7S1D-C9?865D.5]A960Q,V1A9C0W9C$M+0T* ` end XML 10 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6

MET INVESTORS SERIES TRUST

 

SUPPLEMENT DATED DECEMBER 20, 2012

TO THE

PROSPECTUS DATED APRIL 30, 2012

 

MET/TEMPLETON GROWTH PORTFOLIO

 

The Board of Trustees of Met Investors Series Trust (the “Trust”) has approved a change of subadviser for the Met/Templeton Growth Portfolio (the “Portfolio”) from Templeton Global Advisors Limited (“Templeton”) to OppenheimerFunds, Inc. (“Oppenheimer”) to be effective April 29, 2013, pursuant to a new subadvisory agreement between the Trust’s investment adviser, MetLife Advisers, LLC, and Oppenheimer. Effective April 29, 2013, the name of the Portfolio will change to Oppenheimer Global Equity Portfolio, and, unless noted otherwise below, all references to the former name of the Portfolio contained in the Prospectus will change to the Portfolio’s new name and references in the Portfolio’s Prospectus to Templeton will change to Oppenheimer. The Insurance Companies (as defined in the Prospectus) may temporarily continue to refer to Templeton and to the Portfolio by its original name in their forms and communications until such documents can be revised.

 

In connection with the changes described above, the following changes to the Portfolio’s Prospectus are effective April 29, 2013:

 

In the Portfolio Summary, the disclosure in the section entitled “Investment Objective” is deleted in its entirety and replaced with the following:

 

Capital appreciation.

 

In the Portfolio Summary, the disclosure in the footnote in the section entitled “Annual Portfolio Operating Expenses” is deleted in its entirety and replaced with the following:

 

* MetLife Advisers, LLC has contractually agreed, for the period April 29, 2013 through April 30, 2014, to reduce the management fee for each Class of the Portfolio to the annual rate of 0.630% for amounts over $462.5 million but less than $550 million of the Portfolio’s average daily net assets, 0.590% for the next $500 million of the Portfolio’s average daily net assets, and 0.565% for amounts over $1.05 billion. This arrangement may be modified or discontinued prior to April 30, 2014, only with the approval of the Board of Trustees of the Portfolio.

 

In the Portfolio Summary, the section entitled “Principal Investment Strategies” is deleted in its entirety and replaced with the following:

 

OppenheimerFunds, Inc. (“Oppenheimer”), subadviser to the Portfolio, invests under normal circumstances at least 80% of the Portfolio’s assets in equity securities (primarily common stock) of U.S. and foreign-based companies. Equity securities also include preferred stocks and securities convertible into common or preferred stocks. The Portfolio can invest without limit in foreign securities and can invest in any country, including countries with developed or emerging markets. However, the Portfolio currently emphasizes its investments in developed markets such as the United States, Western European countries and Japan. The Portfolio does not limit its investments to companies in a particular capitalization range, but currently focuses its investments in mid- and large-cap companies.

 

The Portfolio is not required to allocate its investments in any set percentages in any particular country. The Portfolio normally will invest in at least three countries (one of which may be the United States). Typically, the Portfolio invests in a number of different countries.

 

The Portfolio may also invest in derivatives, forward commitments, and when-issued and delayed delivery securities.

 

Stock Selection

 

In selecting securities for the Portfolio, Oppenheimer looks primarily for foreign and U.S. companies with high growth potential. Oppenheimer uses fundamental analysis of a company’s financial statements, management structure, operations and product development, and industry position. Oppenheimer evaluates factors affecting particular industries, market trends and general economic conditions.

 

Oppenheimer considers overall and relative economic conditions in U.S. and foreign markets, and seeks broad portfolio diversification in different countries to help moderate the special risks of foreign investing. Oppenheimer currently focuses on the factors below (which may vary in particular cases and may change over time), looking for:

 

    Growth oriented companies.

 

    Companies that stand to benefit from global growth trends at attractive valuations.

 

    Companies with strong competitive positions and high demand for their products or services.

 

    Cyclical opportunities in the business cycle and sectors or industries that may benefit from those opportunities.

 

In applying these and other selection criteria, Oppenheimer considers the effect of worldwide trends on the growth of various business sectors. The trends, or global “themes,” currently considered include development of new technologies, corporate restructuring, the growth of mass affluence and demographic changes.

 

In the Portfolio Summary, “Credit and Counterparty Risk,” “Interest Rate Risk,” and “Focused Investment Risk” are deleted in their entirety from the section entitled “Primary Risks” and the following disclosures are added at the end of that section:

 

Derivatives Risk. The Portfolio may invest in derivatives to obtain investment exposure, enhance return or “hedge” or protect its assets from an unfavorable shift in the value or rate of a reference instrument. Derivatives can significantly increase the Portfolio’s exposure to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy) and other risks. Derivatives may be illiquid and difficult to value. Because of their complex nature, some derivatives may not perform as intended. As a result, the Portfolio may not realize the anticipated benefits from a derivative it holds or it may realize losses. Derivative transactions may create investment leverage, which may increase the Portfolio’s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so.

 

Convertible Securities Risk. Investments in convertible securities may be subject to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy), interest rate risk (the risk that the value of an investment in an income-producing security will decrease as interest rates rise) and other risks associated with investments in equity and fixed income securities, depending on the price of the underlying security and the conversion price. In addition, a convertible security may be bought back by the issuer at a time and a price that is disadvantageous to the Portfolio.

 

Forward Commitment, When-Issued and Delayed Delivery Securities Risk. Investments in forward commitments and when-issued and delayed delivery securities are subject to the risk that the value or yield of the securities the Portfolio is obligated to purchase may decline below the agreed upon purchase price or expected yield before the securities are actually issued or delivered. These investments may create a form of investment leverage, which may increase the Portfolio’s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so.

 

In the Portfolio Summary, the following disclosure is added at the end of the first paragraph in the section entitled “Past Performance”:

 

Effective April 29, 2013, Oppenheimer became the subadviser to the Portfolio, and the Portfolio changed its investment objective and principal investment strategies. Performance information set forth below does not reflect any of these changes. Investment performance prior to that date is attributable to the Portfolio’s former investment subadviser.

XML 11 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 12 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName MET INVESTORS SERIES TRUST
Prospectus Date rr_ProspectusDate Apr. 30, 2012
Supplement [Text Block] mist6_SupplementTextBlock

MET INVESTORS SERIES TRUST

 

SUPPLEMENT DATED DECEMBER 20, 2012

TO THE

PROSPECTUS DATED APRIL 30, 2012

 

MET/TEMPLETON GROWTH PORTFOLIO

 

The Board of Trustees of Met Investors Series Trust (the “Trust”) has approved a change of subadviser for the Met/Templeton Growth Portfolio (the “Portfolio”) from Templeton Global Advisors Limited (“Templeton”) to OppenheimerFunds, Inc. (“Oppenheimer”) to be effective April 29, 2013, pursuant to a new subadvisory agreement between the Trust’s investment adviser, MetLife Advisers, LLC, and Oppenheimer. Effective April 29, 2013, the name of the Portfolio will change to Oppenheimer Global Equity Portfolio, and, unless noted otherwise below, all references to the former name of the Portfolio contained in the Prospectus will change to the Portfolio’s new name and references in the Portfolio’s Prospectus to Templeton will change to Oppenheimer. The Insurance Companies (as defined in the Prospectus) may temporarily continue to refer to Templeton and to the Portfolio by its original name in their forms and communications until such documents can be revised.

 

In connection with the changes described above, the following changes to the Portfolio’s Prospectus are effective April 29, 2013:

 

In the Portfolio Summary, the disclosure in the section entitled “Investment Objective” is deleted in its entirety and replaced with the following:

 

Capital appreciation.

 

In the Portfolio Summary, the disclosure in the footnote in the section entitled “Annual Portfolio Operating Expenses” is deleted in its entirety and replaced with the following:

 

* MetLife Advisers, LLC has contractually agreed, for the period April 29, 2013 through April 30, 2014, to reduce the management fee for each Class of the Portfolio to the annual rate of 0.630% for amounts over $462.5 million but less than $550 million of the Portfolio’s average daily net assets, 0.590% for the next $500 million of the Portfolio’s average daily net assets, and 0.565% for amounts over $1.05 billion. This arrangement may be modified or discontinued prior to April 30, 2014, only with the approval of the Board of Trustees of the Portfolio.

 

In the Portfolio Summary, the section entitled “Principal Investment Strategies” is deleted in its entirety and replaced with the following:

 

OppenheimerFunds, Inc. (“Oppenheimer”), subadviser to the Portfolio, invests under normal circumstances at least 80% of the Portfolio’s assets in equity securities (primarily common stock) of U.S. and foreign-based companies. Equity securities also include preferred stocks and securities convertible into common or preferred stocks. The Portfolio can invest without limit in foreign securities and can invest in any country, including countries with developed or emerging markets. However, the Portfolio currently emphasizes its investments in developed markets such as the United States, Western European countries and Japan. The Portfolio does not limit its investments to companies in a particular capitalization range, but currently focuses its investments in mid- and large-cap companies.

 

The Portfolio is not required to allocate its investments in any set percentages in any particular country. The Portfolio normally will invest in at least three countries (one of which may be the United States). Typically, the Portfolio invests in a number of different countries.

 

The Portfolio may also invest in derivatives, forward commitments, and when-issued and delayed delivery securities.

 

Stock Selection

 

In selecting securities for the Portfolio, Oppenheimer looks primarily for foreign and U.S. companies with high growth potential. Oppenheimer uses fundamental analysis of a company’s financial statements, management structure, operations and product development, and industry position. Oppenheimer evaluates factors affecting particular industries, market trends and general economic conditions.

 

Oppenheimer considers overall and relative economic conditions in U.S. and foreign markets, and seeks broad portfolio diversification in different countries to help moderate the special risks of foreign investing. Oppenheimer currently focuses on the factors below (which may vary in particular cases and may change over time), looking for:

 

    Growth oriented companies.

 

    Companies that stand to benefit from global growth trends at attractive valuations.

 

    Companies with strong competitive positions and high demand for their products or services.

 

    Cyclical opportunities in the business cycle and sectors or industries that may benefit from those opportunities.

 

In applying these and other selection criteria, Oppenheimer considers the effect of worldwide trends on the growth of various business sectors. The trends, or global “themes,” currently considered include development of new technologies, corporate restructuring, the growth of mass affluence and demographic changes.

 

In the Portfolio Summary, “Credit and Counterparty Risk,” “Interest Rate Risk,” and “Focused Investment Risk” are deleted in their entirety from the section entitled “Primary Risks” and the following disclosures are added at the end of that section:

 

Derivatives Risk. The Portfolio may invest in derivatives to obtain investment exposure, enhance return or “hedge” or protect its assets from an unfavorable shift in the value or rate of a reference instrument. Derivatives can significantly increase the Portfolio’s exposure to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy) and other risks. Derivatives may be illiquid and difficult to value. Because of their complex nature, some derivatives may not perform as intended. As a result, the Portfolio may not realize the anticipated benefits from a derivative it holds or it may realize losses. Derivative transactions may create investment leverage, which may increase the Portfolio’s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so.

 

Convertible Securities Risk. Investments in convertible securities may be subject to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy), interest rate risk (the risk that the value of an investment in an income-producing security will decrease as interest rates rise) and other risks associated with investments in equity and fixed income securities, depending on the price of the underlying security and the conversion price. In addition, a convertible security may be bought back by the issuer at a time and a price that is disadvantageous to the Portfolio.

 

Forward Commitment, When-Issued and Delayed Delivery Securities Risk. Investments in forward commitments and when-issued and delayed delivery securities are subject to the risk that the value or yield of the securities the Portfolio is obligated to purchase may decline below the agreed upon purchase price or expected yield before the securities are actually issued or delivered. These investments may create a form of investment leverage, which may increase the Portfolio’s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so.

 

In the Portfolio Summary, the following disclosure is added at the end of the first paragraph in the section entitled “Past Performance”:

 

Effective April 29, 2013, Oppenheimer became the subadviser to the Portfolio, and the Portfolio changed its investment objective and principal investment strategies. Performance information set forth below does not reflect any of these changes. Investment performance prior to that date is attributable to the Portfolio’s former investment subadviser.

Met/Templeton Growth Portfolio
 
Risk/Return: rr_RiskReturnAbstract  
Supplement [Text Block] mist6_SupplementTextBlock

MET INVESTORS SERIES TRUST

 

SUPPLEMENT DATED DECEMBER 20, 2012

TO THE

PROSPECTUS DATED APRIL 30, 2012

 

MET/TEMPLETON GROWTH PORTFOLIO

 

The Board of Trustees of Met Investors Series Trust (the “Trust”) has approved a change of subadviser for the Met/Templeton Growth Portfolio (the “Portfolio”) from Templeton Global Advisors Limited (“Templeton”) to OppenheimerFunds, Inc. (“Oppenheimer”) to be effective April 29, 2013, pursuant to a new subadvisory agreement between the Trust’s investment adviser, MetLife Advisers, LLC, and Oppenheimer. Effective April 29, 2013, the name of the Portfolio will change to Oppenheimer Global Equity Portfolio, and, unless noted otherwise below, all references to the former name of the Portfolio contained in the Prospectus will change to the Portfolio’s new name and references in the Portfolio’s Prospectus to Templeton will change to Oppenheimer. The Insurance Companies (as defined in the Prospectus) may temporarily continue to refer to Templeton and to the Portfolio by its original name in their forms and communications until such documents can be revised.

 

In connection with the changes described above, the following changes to the Portfolio’s Prospectus are effective April 29, 2013:

 

In the Portfolio Summary, the disclosure in the section entitled “Investment Objective” is deleted in its entirety and replaced with the following:

 

Capital appreciation.

 

In the Portfolio Summary, the disclosure in the footnote in the section entitled “Annual Portfolio Operating Expenses” is deleted in its entirety and replaced with the following:

 

* MetLife Advisers, LLC has contractually agreed, for the period April 29, 2013 through April 30, 2014, to reduce the management fee for each Class of the Portfolio to the annual rate of 0.630% for amounts over $462.5 million but less than $550 million of the Portfolio’s average daily net assets, 0.590% for the next $500 million of the Portfolio’s average daily net assets, and 0.565% for amounts over $1.05 billion. This arrangement may be modified or discontinued prior to April 30, 2014, only with the approval of the Board of Trustees of the Portfolio.

 

In the Portfolio Summary, the section entitled “Principal Investment Strategies” is deleted in its entirety and replaced with the following:

 

OppenheimerFunds, Inc. (“Oppenheimer”), subadviser to the Portfolio, invests under normal circumstances at least 80% of the Portfolio’s assets in equity securities (primarily common stock) of U.S. and foreign-based companies. Equity securities also include preferred stocks and securities convertible into common or preferred stocks. The Portfolio can invest without limit in foreign securities and can invest in any country, including countries with developed or emerging markets. However, the Portfolio currently emphasizes its investments in developed markets such as the United States, Western European countries and Japan. The Portfolio does not limit its investments to companies in a particular capitalization range, but currently focuses its investments in mid- and large-cap companies.

 

The Portfolio is not required to allocate its investments in any set percentages in any particular country. The Portfolio normally will invest in at least three countries (one of which may be the United States). Typically, the Portfolio invests in a number of different countries.

 

The Portfolio may also invest in derivatives, forward commitments, and when-issued and delayed delivery securities.

 

Stock Selection

 

In selecting securities for the Portfolio, Oppenheimer looks primarily for foreign and U.S. companies with high growth potential. Oppenheimer uses fundamental analysis of a company’s financial statements, management structure, operations and product development, and industry position. Oppenheimer evaluates factors affecting particular industries, market trends and general economic conditions.

 

Oppenheimer considers overall and relative economic conditions in U.S. and foreign markets, and seeks broad portfolio diversification in different countries to help moderate the special risks of foreign investing. Oppenheimer currently focuses on the factors below (which may vary in particular cases and may change over time), looking for:

 

    Growth oriented companies.

 

    Companies that stand to benefit from global growth trends at attractive valuations.

 

    Companies with strong competitive positions and high demand for their products or services.

 

    Cyclical opportunities in the business cycle and sectors or industries that may benefit from those opportunities.

 

In applying these and other selection criteria, Oppenheimer considers the effect of worldwide trends on the growth of various business sectors. The trends, or global “themes,” currently considered include development of new technologies, corporate restructuring, the growth of mass affluence and demographic changes.

 

In the Portfolio Summary, “Credit and Counterparty Risk,” “Interest Rate Risk,” and “Focused Investment Risk” are deleted in their entirety from the section entitled “Primary Risks” and the following disclosures are added at the end of that section:

 

Derivatives Risk. The Portfolio may invest in derivatives to obtain investment exposure, enhance return or “hedge” or protect its assets from an unfavorable shift in the value or rate of a reference instrument. Derivatives can significantly increase the Portfolio’s exposure to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy) and other risks. Derivatives may be illiquid and difficult to value. Because of their complex nature, some derivatives may not perform as intended. As a result, the Portfolio may not realize the anticipated benefits from a derivative it holds or it may realize losses. Derivative transactions may create investment leverage, which may increase the Portfolio’s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so.

 

Convertible Securities Risk. Investments in convertible securities may be subject to market risk, credit and counterparty risk (the risk that an issuer or counterparty will default or become less creditworthy), interest rate risk (the risk that the value of an investment in an income-producing security will decrease as interest rates rise) and other risks associated with investments in equity and fixed income securities, depending on the price of the underlying security and the conversion price. In addition, a convertible security may be bought back by the issuer at a time and a price that is disadvantageous to the Portfolio.

 

Forward Commitment, When-Issued and Delayed Delivery Securities Risk. Investments in forward commitments and when-issued and delayed delivery securities are subject to the risk that the value or yield of the securities the Portfolio is obligated to purchase may decline below the agreed upon purchase price or expected yield before the securities are actually issued or delivered. These investments may create a form of investment leverage, which may increase the Portfolio’s volatility and may require the Portfolio to liquidate portfolio securities when it may not be advantageous to do so.

 

In the Portfolio Summary, the following disclosure is added at the end of the first paragraph in the section entitled “Past Performance”:

 

Effective April 29, 2013, Oppenheimer became the subadviser to the Portfolio, and the Portfolio changed its investment objective and principal investment strategies. Performance information set forth below does not reflect any of these changes. Investment performance prior to that date is attributable to the Portfolio’s former investment subadviser.

XML 13 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
12 Months Ended
Apr. 30, 2012
Risk/Return:  
Document Type Other
Document Period End Date Dec. 31, 2011
Registrant Name MET INVESTORS SERIES TRUST
Central Index Key 0001126087
Amendment Flag false
Document Creation Date Dec. 20, 2012
Document Effective Date Dec. 20, 2012
Prospectus Date Apr. 30, 2012
ZIP 14 0001193125-13-010283-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-13-010283-xbrl.zip M4$L#!!0````(`(U2*T*Y?V6RS!```&*0```2`!P`;6ES=#8M,C`Q,C$R,C`N M>&UL550)``.Z+?!0NBWP4'5X"P`!!"4.```$.0$``.T<:W/;-O+[S=Q_P.G: M3G*CIQV[C>.TD]A*ZZM=>RSEVF\=B(0D-!3!`J!M]=??[@(405E.[<1IXP03 MST02@5U@W[M88O^[JT7&+H0V4N7/6X-NO\5$GJA4YK/GK=)TN$FD;'WW[3__ ML?^O3N>7E^?'+%5)N1"Y98D6W(J439;L_)P=JCP762:6[.B$G6F5"&.49KO= M/OYCI0&0[%7YF[2F9$>Y!9R6SP3[Y6>>IYT.8KB:Z(S!@G*SMY#&[CYOS:TM M]GJ]R\O+[D+83$Y%-U&+WE9_L#78VH+%NM%71C;&7FYWE9[!L/Z@]\O)\2B9 MBP7OR!PPYHFH9J6BGH6HNT8DW9FZZ,$#0M'I#SK;@VJXUIM':[UA<";S-XTE MT12_J.T>/IYPLUH*/DW75N,'[_;71;B>%QHD.,4P`R9-V MZ;_!=YGB+U,I-*,%B<8N*B8='/W8^K8/\C#8VNU_\_5^KYY6`>XU(.\70DN5 MUGA@_]H>@L!_BPOK]'>`X?N]^M?50)&GU3`0BB>=[3Z"3H-!^[T`^'[/D^!N M]!C!9OI;@Z=/^K^>B,5$Z`].(*2!F*'FKWZ`GYQP[HFK(I.)M&XM+)4PSMD4 M4*:]8S'CV9#6]>)*FM:W)!![]1[1F@U_EYS`1\)R[3>`WMG"I'8TN`< MYA^?H^R_7:A#C-?@./!(P$-O<\>@8G>`?FKG2-5U"#5&>$P-$`XR-XHE`7X#Q)5`/HR M4\F;.V#X*K//"F;L,@,SM^!Z)O..5<5>O[AZYK].E+5J@;^T&,_D#&Q4(C`> M:7TUL\\0P!3053#P!YBQGY!PS97DV;E8+A MF-ZD&MU#V*LO!7YBMU]_9Q M6?Z7$>N]J#.>"_92<9TR-65C71HK8#!\/A$64KL+8:S2AHW`><#O-(`]@E"$ MT2[^/7CR]3/ZL?KZS;/';,X-XT6AU05DE)PE6K:0(&D&\X,1JS-G0@F*H?.P(?)K.;S MUE/2R.TV*TIM2HB><`8GGE0T47K)^$P+PR4YO!*,(+G.`)AV1ZFA[?96-B2$9D?H$'8D4X*\@;IH3H`'0M=#=3)DN0Q4[ MR@W$.@">':A%P7-4ID>@)JF8;M[%8[;@2V8!@=(<&.6":9F7!)]6VUP!;F)] MMUC.D1;464NP&<`>VJ[#)4D'%X8F)FJQ*'.94#1F@%U69B"9R7Q5(3(LX3D* MN18H8&F7?4Y6\BA'\N>H.<1LL%%(:,=PY*))M)R@M9N`T6M[^).QAB%:E;/Y M^G.?J3UI.Y^>EA`?(#18&)^Y0'`J*!)B@H,S/LBX,=>#(>]7N!,2C>4B&-/O M[F[WOZ3)?*%*=.'@FS3[XLGN5G>'`34RE+9):1D%9Q:\%/MB9Z>_>K2.*/17 M'$#AD4_*,3;)(5F`I0D+!.MW=YYZO!1)8@7\BYW^^X)%R070NSN;MC3H]G?8 MQ,''@$NB%]7H=8F(&$I!Z+)0*1;!(0+5I(X^H$H9<$51.'4C?U0.RUGIBTMN M@-9^*QL3J,8>HR6L+>%;[-R9EGDB"Z!LX*9'%D5Z)J.-NP\;]ZXY;CO,WM*L1()5'O@J73H+$E%I: M2II`0Q=50K18@!@9JY(WCQ'@Z^ZH2]P'`R'D#&C((5/!<2[CZE;I:0"/9T8! MIB0K4[#BE%>!(79`76X4#`:+`>;&RDF&3MNJ:@E@/-:GNK0O2%C!N#H:D4@J MM+I8F,!=^N4VEH5)63U%8GZ'.P:;AVKD%DRY!?V$4TC24W$!.77A;!P8/Y2; M&H#"%,M+57L)%"LA62K1];`HY+!Z+<%=A!`H& M=MA#D8+6@RZ>6;!ZJ4,^$SDL)F,"XB"UD`G&0RDANQ?E_#2":B2*D6#]7&Z* M9QLN(KVG/JZ/5G=ZWX*/?1< M9`6FOX**`Y2$%8(D4$OSAB2UPNLL.,A%4X"NQU#*5[&\/-%9#GM4>]X+2/AP M28T0S?CH#P=4YX*8P2-U(<5`%461A,5\+&F:Y1CM>VP3I8&&G01R25X8L5=] M:#'WY'FKWV*)R+*"IZ[OUG\W!4^J[YW7+Y- M-T#;^K(%3'$'ZT"OU2$[:L#['[&_VT1O%9]>W\,[+Z1)B3\GRV"-+!MHVYP7 MDNWZS'==NC_Z5J"RN6UFK3=MQ'W4]4<4U:@B444^416IC\[MG.-T?^8]@;AD M*JUK!)FY1@0?LU71BX4_*M^C"W:QT$UA2]2MJ%N?LVY1W@-)@*+JXJ(05I+6 M5(F%"^`H,4K%PH>LOJ/$IR?8<0(QJ[Z02?1?4<>BCGD=6R895ATAJ<=C5?KH7-0=XH5U(80+Q+! MBF2>JTS-J+*3*(U=A1:;^:I2$]"BO;;@!38;\.DT*[$OTI=G%VJF>3''^H7K M:GMH9=D/=;)=L^L`F`%:B?0ZP"*,T%@"6;)S:=Z$3`Q[TF`0ULW/D2GKXQ!0 M/?85E5_2\(`<)X3CM0C/QIUG7IV.>V/Q9\?PN"D";-96TFQMK+N:7-\B^$2L MY%NG'7GJSGDQ6'?8/I:JSM]D>7`BO6)P6)^.$)6[M#YZQ*X?K6P\5<',1TVP M"SIL"!=7!;&C#=2?4\,Q<+W4=$9=,W@NTEG8]4@'V,JB+<,S/'\`3Z+"*QMP*%2W9)L&!@N M+;@1-W<$5+O"/?NZ-!8NV_C>>J5K2:AK^-2]/$"?2`3Q.!U/FC2NN#&:CA=3 M,>5E9O'A1$#@*UQ;E,,`YMW.EX\#1T&%T^;._'DCMB']7DI_H"6G4ZQ^4L<_ MT:O+7HJ$EZ;J:I>:PNQ,7+&SI&F0\=2V$QJ9M/'&7L/P\Q4;L%X;H M;@#)^FEF-0_(FX$8^C8Q*[''AE[W=Q%$Q>H`)\@!FZLL=<&'BSMPRZ.CY>A.<(SNB MK6ODP?$0GC566T&B3-!<77`ZE%:NH3^%"0^N5^L#F:B#H-EE5%-QW5H=-<_[ MPQ:9@/9>-4Q)+==_MQJW27O(X[HP:`.:P+Y-&6_86.I?0-D%Z!V7\@8GD:MU M>-'VNKK"9A")N&9*T.@J[)NNFM;6&BE\*Q3EV_+*A7NXNYK(;<`)@2JU!?GH ML]"0@5>]5M2:Y:+>U5(KC^[8AF_YNSE=AD%RZ@ZHVG2,>8VORXJK$^QM!7WB MR1M\XP3A>0XAN^ALAQ!QOQZB+S;P2;.N@`^Z:?(#*>(KWSQQL&J>:+.?L6_B MJ.Z;./1]$X=5W\3M-79#;\9=6S,H]`MT^T9-TFPI1996$AE`6.O"`;(^HR2I#0%P'DU;L)9$M)UU$:K=5R4KK*]=O>*_1OT89;6-'J1K7? M[]UX?\=]7>^QX-]'O._C'O81[_OX9$4TWO<1[_N(]WW$^S[B?1_Q MOH]XW\=#HW^\[^/C3M;C?1_QOH^'+L/QOH]XWT>\[R/>]_$IV[AXWT>\[R/> M]Q'O^XCW?<3[/NY-*.)]'_&^CWC?1[SO(P;5\;Z/>-]'?!GTUA/CRZ#QOH^H M(E%%XGT?4;>B;GT4NA7O^X@Z%G4LWO?Q2=>/XGT?\;Z/^SW9CO=]Q/L^XGT? M\;Z/>-]'O._C(0='*Q,5[_N(]WW$^SX^`D6,]WW$^SZBQXOW?7SRV5&\[^-! MW/>QW[N:Z`P^_!]02P,$%`````@`C5(K0OM=9H'O`@``WQ(``!8`'`!M:7-T M-BTR,#$R,3(R,%]C86PN>&UL550)``.Z+?!0NBWP4'5X"P`!!"4.```$.0$` M`,U8T6[:,!1]G[1_\++GX"1LE5K!*K:N4Z52*KJI?9N,F[ER\ZK\+P[OWPDJ2:YQDH2S@"LY"2T0,9#LF95@JDA`=RT2?7J#D8HY$< MM2+_);EQE.0\_R:LR)$*=,-IM;.3BB= MS^>MQ0AE2^.$)E'4IB4P6")/_%&Q`2^4JZ7X'[PGJ.#G[0(='Q\?T^+H&FK$ M8T!'&].[_N4-GT+&PG4!-PU".J@E#&%,_.^7X46%(`,KQ1A:7&?4'Z>>(LTE M])3*F3S/53J8`3+K_/JXF($R8/I@Z6?(9A*L5I]0S^WT6J,=:RFT$^KUGMB' M&70#(SRJ_&^*,.X&F3#V*$RB.(F3)&HM3/JZ6)VR0D):W;7#(33TW6W*0D)S]#4BE`EA7(NL2O M9;YNYE+SRFS=/K,:J\:O)EN<(B34;S1].;##C"$YN)7H21[#&6` M-R(3DN&55D^*9=O``P]FF_Q5-.T=1S.P4\"M_;X6=8"FUVI=.?QFQPY_T-E, M*]-\#OQ?4MZKWU#:3O:5E8*TN>&$(]_N!#J)>^IV5@K:S]Q!#J\00'A7R*M7PZYG=]02P,$%`````@`C5(K M0G6]#,,))@``R+$#`!8`'`!M:7-T-BTR,#$R,3(R,%]D968N>&UL550)``.Z M+?!0NBWP4'5X"P`!!"4.```$.0$``.U=;7/;2'+^GJK\!YSO2U(560)E>RW7 M.5>R9.^J(DN.I,W>5BJU!1%#"6<0T`*@7FIK_WMF``X)`O,&2IQI$)T/.:_8 M`SP]F.YGWKK[;W]_G,;>/Q85WG"8)B6/RY'FSG#;W MF/!1G,Y"[YA,HB0JZ"N\TRCY?AWDQ/N1)"0+BC1[O;/#GA[3'S[$_%>**LD_ M/++__OCJMBCN/NSN/CP\O'[8?YUF-[O^P<'!;OGK*RZ:1R+!T=Z>O_N/KZ>7 MXULR#7:B)"^"9$SFK59:/%YG,6^SO\N1+)Y/?PV+18.Z\-O=ZD M?32]BQFD\F^W&9E\?#6-\N(=?8X_\D>C/?:4OQ[//SW_WR`) M/R=%5#R=)),TFY8ZO/+8"WZ^.%E19DJ*.)J0U^-TNLM^WS5[U.[+XKZ(\N\7 MI)AER>7LCC9D?_LYB8-K$I/P*RFN"'MSF%S>!AFY3>.09%\(R9^OG_S!]I0Z3))9$'^9 M)>'Y'?.6U*U^?KPC2?Z2"JI?8D_9^4L_/P:LV546)/E=FK_$4#5X@RLUS](+ M$M)7,W>W>96E;[,]I*_2(H@KKZ$:R9^"[(B:7['6B&Z\0ZKB\B4OK2J=5P4W M`C2;^-!F+]O\=V[3PC$I@BC>*/.T7V%!T2@?QVD^RT@3QW%0!)\KUG\!-VW\ M'D.5@VQLJK5DJLDGO&R.^;;LBUOZB&P\NR8[843AY.7<;?ZBNH*+IT1)L4M% M=^.N.R9G2F97I.L(]K5 MIIM&&L1Q-WQE@SDJNC+V?N(CN+[:_;?#./[W+']E*>`4_>2Q($I*0 M:\!>\Q)KJ/D[HH(];J_\/V_'XVWJ_Z3MO>H!7OT))7RN0)R.5U#';.F:9L)N M+SLO)^/7-^G];I;M,O])_[?THSM[_GQM^MOD12W_^ M\95(8-<"JJ7#/;S.BRP8%VU@(IE5;,M/?IBMHJ1CB3]P/JP,QUW59I*E4RF& M^7M2<>^E&5W.?'SE4[G2$#XPBB'AQU=%-B/+/Z9)04?EG&.HA9$;]H_%N-\5 M#.FE19PDMR2+ROT6CPXFMO5#O)."3/,/GI=E']JHT5)LCTC[(@/J$F^/A?Y$D*LB5G">4A_8@A^Y!?XN!&@*[QNVU4QR0?9]%= MW>6(P*V(6<)(UXILY__R:7J=Q@)PC=\MV^\1.V^@W:$QWU4QRQ@_3R:49Z-[ MH@'9D+,QFUE.`@38!+]O60YF^D#Y@:]S,&/8(,7T\X<^WX? ML+?8:`[^#6SP#;*:@W[;$]`K)#;'_@XV]@;'S4'_`!NTF/OFV-_W`WN#$N?@ M#^""%W`F9Z(]PS6RRUVC]4^I6^MDO[%.9H_>K9[M+1_N_;%X_)]4:&7+VJM> MXBW?@KM.N.NT);M.:&D6=ZT$1W7EGWY;=L\5_92?:./O#1`*.:@#LQ1DSF>YSU':]^9\.'Z-,A;;%) MTQ*>*S<,3-+7S>FI%']'.SLNK9V.,6;MN8>&U/LANW'DQ_,+!E*@QRLW$#;$ M4JW[#G4[ZM#13L;&:'R;A91"SZ^OU M%=42MG%#IUIT1B]&;7,6H!W@4M[$)+ON'H9Q/)T0[[!+_N^M;W]5O_B1@EH1P.3@0U1E='.1W&0 MYY)UJ502,!\K<3>O@2$O@S27EQJ8F\&Y?*=LJZ0M\9),?<0^\+O]O;>^@JG; M0IN`\.:]`82ET$8@')A`.-@DA+>J*5-;R.V^@,;(YBZT/8*A;-88X)=9`)2M MFQ-S"0FI/RM\^:E-N_^#G@&06D"?C6W_E\.^0[ MGX,S,L=!RH;8?B)EI(<*VD+$!K+SZW]6`1!28&T)J[B^91$;;K+KLVI1JT@O M"?4HH2%6D;`-M//<7-*OW?S=(J:S(&.9X.Z)HO\4HM:6W,N\?$>!**):(><` M8TF)BA[5B%NQH&8*0&F_RB6MW)J0)RW4]7*'IA8M[DN:%DE:4`Q:BQ.)6D2: MTQ4+R3(2LJQY-R:`%2ULXKX(DAMR/OG\.+YE_RI-3(]=WEL'VTOT3%;2WWJ,9%=VGK8,34LJBN M,7HTK=WJTVE4*1JZU:+;^%*UM*]'AXF`HH5]W$=QRM+^&Z-NRULYZ>;;(%=T M=9_>$SE-R26=X%3TJTK6RBJGH$Z,W#Q)N[(E8!.5B8=6R=K:DU+N1EGM.?9" MDUZ3R=G":.(I97*V,.J]HEC*!CZ>^/PP"6M7PTL&E`Y&DS:68U1,AJI&W&9O MF\!5R=K$JAT&5K\Y?ZEN=B>3LXG1Q#>I9&UBU?LHN:1E6U<[)R@>J7QY1[,">P?(EI%^#;+OI"B3^'4`;=;*14^;^`F3-BZPZ_V&O@74O#KB4V#GX0(F MN-N'Q/!3C*J/CN&G&=4=)\//-2HX;X:?:U1]"@T_WZCB>!I^WE']@37\_*/* M<^Q>9"#M<)K=2DX*4B'%(3=7`#;_Z@^]N1ZP"=GL`)SK`IN<)6?C''PO>%E\ M8,Y5Z`5+*P[0N1ZPV5IYJLY5@,W97<[6N4:P&;S;^3K7"3:M&Q^T\[5=+TC= MX,"=Z],+CE<L'QTB-YK@5L=I=8#/-8#-[ZT3?@X;-IVK MSOVY!K#9?.5R`(<,FZYEUP8X>MC$++M0P/D-)TLO67!-8!.S_M(%U\,XYQE/ MG,*2E02SN,"\9\^_:H-E2VR7+:G&[JI!V:];@L:$-1=LU%RP:D;:7C9-_#]" M*X)+25N9(MLZW:R3H-HX:SR:!6:HW5"&6NN$\LRTI*:K&RCYT2_'MR2\V+A4"PJ`0Z&AC(H6P% MY5$:SZ;)63`5.`2%J)V4R(_1=#8]FDUG<1D(61[Q5%GGSN])=CZ9T-&>W'S+ MHK$`?"'%JD$&H>Q` M)X6ZSA,A5"7HI*#9A!%"W8(746ME&#I-Z[3N,.PZ:X10]I=6J;M-R7G@W9PJW],V#1(0X/)69C*J7>IG(9N*H/< M7,,D3YCD2>V\H,4E8I*G+4WR-'3^@;J]@.F?<&KF?+M@*T]R,#&4T5D2)H9" M%MYZ%L:443U-&84&,Y!C9DPF]8(0,)D4)I/"9%+@5&<`N`DO/4I MY-EY%**V4TUI44-.-B4%CR;8P\%N":DJ'952V$["B22X*6V%7156Y\:02=K` M63]@8H=F)+N/QL0?7?LZW.8M;>MQGEU&TR@.LK,TZ:J)KJT-78[2Z5V:T`'A ME^&,?`BK5#!H8A7YJ#MR>1.KR/>[(Y(73?$Z17DX_GT6921D;%A&\R:A M"6;#9G;2+^GANL)&N^:7(&(I)+(+$DVO9UE>,HH*JTD;&]C/2&'2M1(Q=^'I MIA-NY53$^IC$R5,)PQ04AR9*J2`K_;_$:F"IA,M4`D M/C)52#(9:R4]@A@4OOT;?AB2APEYT)PPF@A3]?0H5<_VV]$@KWYC$A\TC.E=K>K-J3?/'>O/G>G\LG_PG.%L" M%GJ'F7UZE]EGJZW(^7@=W`X")O49FHW!9"K,Y].[?#X#MI)!;KYA*A],Y:/V M6]"BPC"5SY:F\ADP]4#=2L`L/C@APU,<3."#"7PXW"U-X+/57@8F]V+NGI[F M[D%;V?[C8TS;\X(0,&T/INW!M#W@5<"T/4[2]N!T`M;4>_5[R#.8R.1LY^I1 MXX6,'"VN+V/;!L9/3[^2(%-EY]')V\?,$.SY.J11-F)=^&]A9(=8 M$SXSW8ZK""<1+5L]F<&KPQA\C):$5Q\Q[K@?<<=;;4*#O*R"(<=H$WA3@&YGPH#VZC M`6.4T?R`\QN&+_<\?!D-:,#;>QC9C)'-:I<&[>(L1C8/(K(960GVM@4&/>,T M#N@VQ%8>,6$\M-$A%\9#(V,/E+$Q5'HK0J71C`9V+(Y1U"\(`:.H,8H:HZC! MJX!1U`"BJ'&F`7C"+O]4I@&IXC9N`Z]5>O0G"%ND!1HO@%CM39F);>Q=X[G5 M;=WJ8A;G+6H!`+!46(]VW+-)].-8UR!M* M&`2/YK+1[?EMOPB`\?%VKJU51>BOTB*(+T@QRQ)E5?M/079$>Z`0&=<[877[ M\LG>_-&>SHB\_^5O^+^M/NUROJP#=6%M*^+@M]V0G`_9P>U$8+S[`,T,)E]A M7'OOXMJ';2B#W+3#^'6,7U>[+FA7EC%^?4OCUX?-/E"W%3!.':=ECK<)MO*T M!^/1C487PY>!8PO=Q)? MCC,*C.T-W0"5_9BU7U'07G%5G#J M)A*RCDX1:RZ3LXWQA!I?V3W'0:&!V1"UC=0_.!!$,KJ/%U9KS6L$ER#S0EG"`ZYT6USLGN'[0XOK!":[W6ESO MG>`ZT.(ZL(]K1&=0:ER5A`-<&G]?23C`I?'WE80#7!I_7TDXP*7Q]Y6$`UP: M?U]).,"E\?>5A`-<&G]?23C`I?'WE80#7!I_7TG8QR7*5-26<(!+Z^]])_[> MU_I[WXF_][7^WG?B[WVMO_>=^'M?Z^]])_[>U_I[WXF_][7^WG?B[WVMO_>= M^'M?Z^]])_Y^I/7W(Z>9Z$PVSH4;C<[OJ:T#OITESVDZN:[X&[N3$%+'=56A MVK^$D!UN#>1^^U"U)\A'"^0M-@..?)DBL<5WP)&_62!O,2)PY,O\C2W.!([\ MW9*8>D6KU78MA]XK4JUV=#GT7O%IM>G+H?>*1ZM]80Z]5T1:;1USZ+UBTFIW MF4/O%956&]`<>J^XM-JCYM![1:;5-C:'WBLVK7:Z^3*I5VQ:;89SZ+UBTVJ_ MG$/O%9M66^H<>L_8M);<>]0S-O5KR?%[QJ;^DDU'/6-3?\FFHYZQJ;]DTU'/ MV-1?LNFH9VSJ+]ETOV=LZB_9=+]G;.HOV72_9VSJ+]ETOV=L.EJRZ;YQ&*N+ MS,G;?@\>,U%B30PT)DRCA[4O>E/[8MNM:)!9C[#&!9K%+`9:)$@M`52_0 M]B`S&Y;"Z%\I#+0>W-C;&$ZLCX'U,4"6DL#Z&#BAZQ$E0=VJP*(9.(&#N/6P ME6=*STL+C94TL)(&>I\MYFHLK]'7\AIH0X,]_GX>IV/-#:RY@34WL.9&OU3` MFAMN:F[@-*,74_65[U3UGKQF@5+8=E$.`^202W,HX*-UVK?.3=F!-;2G#)T1 MU+FD(YR_DB`3IO^6B[I$*DHL*A=UB%28^EJL)(?;25%W?Q M@[F_@.'[F[UGQZ>E%U'^O1KPQZ0(HOCGI/Q&W2WKO<=N.%4/I?]DS]VM'NQ5 M3_;^6#S[3VU:C*T^I7.^E@-UQ:[7S23@6[388@]AMBK'1>T&]888K]E(?;(/7"W$S"6'J=D3K<'MO)X!X/FC0Z8 M,&@>V7>KV1>CXWL6'8_&,J!C9`R#?T$(&`:/8?`8!@]>!0R#MQH&C_,)H)/O MY0>1A_>*9&Q'M\MQ0@YJ;Z-&$P,_F#>-K>J\T<_\B3[_NPJG6-Y=*)W6 M%'70(4?W#,.*\*X:!LJA*>%5&XR(`QX1-PP;&N39*(:^H5'@X03&N+D^%H]R MMC%"^;!I3L=!$X/)8!@$UY\@.+28P6_283PR(%UI:PBNM;%DV#[$D1/ZH0M8KTDE!N"`VQBH1MH/W\>$>GF/*OW?S= M(J:S(,L"UC>*_E.(6MM%N4UC.E'X0DA^%$B*&BQ`W[$Y"(V*6]&E&L-F M%C6H`3B9EC6OSI-OLVQ\&^0D-_\V71]C44.ZJB591L*UQIQ98P#:*,>;NI&; MT7:>7)`HN2=Y0<+CZ#X*Z:*&76E:N0VD5^T93[0R'R0A7>RP-U._R]Z]_(-@ M9J@2MHY6@\_6C(&ZD.2&&/2>0M0R4B4VJ_9V.!ZGLZ28=\EAGI-"<&"E%':" MU@"CBSF6Q!4)A:RL2.X(FQTG-_/9LGR>*I=T@U,Q5U4*VQF-27!3;AZPN;+: M<&22-G#6>8W=!2;9/9V-^*-K7X?;O*5M/[FF5)2M%(=WOEDDYP*C9^5;). ML%Z(3[G$8A:]V9$\HZP?HU2MA*_Z3?!1<94%8S87HW',:Y>SRE_QK:%I9M0%REY&<=N*GM+C]&N0%Y;QR M0A>*MD+,6MG$3_\W#BI2/I_0E6%&QK.,[=VK=ILZ-;:^4C@C#VQ(?`K*8Y;/ M>1%-*?GHE@W25H[7$'HU.C6VNIZH]^]/`4559$&:T8E5D#TM(!*2G"3C>%:[ MLR58=G1_E%TOD!>T?\.K](),8C(NCJ@=$(4W5K2PB?LL+8Y2^MYX#H69\O&, M7*7-,257I,,CK/)*P"[1Z:YW-,7L(_ST]"L)Y`L3I;!]M!VNIBA:N.IEZ?:_ M4M@^6O;Z/5\'DTLYPK=OA*\5ZV`-WULC?&]=X?/W3/`Q*0=6GBY/A]>P>$UK MM_IT\@2*AFZU,/,0HA8`<&L]AZ@%`-Q:CR)JX1ZWWM.(6MC'W6'#3M'"/NZC M.,WI=,P8=5O>RDT-NEXJR,V3=*;9$K")RH1E5+(VL2ZVMH_29$Q7;)GD6$0G M;RO>0AEI8?5KLQ>:?&F9G"V,)IY()F<+H][KB*5LX3M-<_(U3K$X25A$8WA, M[NC@HD]]HG\HHF(FN;5KTLB:U2 MS(*XXWFAQM=*56<$E."]H2SC`]4Z+ZYT37#]H^$W_O:_V][\3?^UI_[SOQ][[6W_M._+VO]?>^$W_O:_V][\3?^UI_[SOQ M][[6W_M._+VO]?>^$W\_TOK[D25_SWYKJ&1M8M7?VY!+VL1Y08(\32X) MVRLF855,(&)IW5@VERR=GDRG)(R"@L1/WS(R)FRW_AO)HE1P8>$EGFE7]_*0 M\DN:E1C/TJ),:$?"DV29O5>EIE%S&QJQD\RKE.W\5J!.&=@V(UQVH'YT_1S2W)B_^>400DBY^4WU\I;/5<4`A$/194;=QC[XK;#N;3 M],%X<*AD;?:O$(=Z:"B:.$?>$;7U^P7J:U=0[EJ5+VN*Q:W49OULI%W__,(LHK7_R% MY5^@ZQAQ2AO#=BYT*.]UQ.0^2(JKE/8ESP^CUT+>TH4>YTE5R^E\PBN@7]ZF M#P)?:=S0A1:UM!@<33E0!`E!.C1U,JZZ7665MG&!?;'2KY:=XGNJ?)&V]MK6 MSEN=]E^';^]J=Z6)0[_+HF]A96?MGO+&['*>0=855=55.+>X(L62-(Y=T MA%,6X*T0=8E4=!0B%W6(5'A8*1=UA/0R*OEB?G'3"'&SB2/DNHNIVA8V<->" MYR[)/:%O?OHU(G$H=;W:!DY1*YRP21N7V"6A(AIQEXC-P3K#2=<,GW^?1?=! M3&>6YJ!%S6QH<'4;9<63U@8E8@X0*NQ-+FD?I\2VA$+VT>F`6<9D8C-*X56T M+UP.NRR"O3-=J5-O6.!77@S54DWX9V#/VM52+56!?P9H18552_7?G]?C@OJK MEHJ^/P]WNSQKL]`[;-CMHJUS_*W+6C#Q7PH*N_UTB(<.&PJ%]:_Y=!A$[6\+B[' M#YN5E<5RN0K0V5A61)?CA\VRYL5TN3ZP*;=+25VN$6P^-JBPRWKY<$]AD+BGUR\'#9O*U MZOQRU6"3^C=I_5^.'S:%M_"WSP/>P.;NE@87]?/>-[#Y6E%'F"L`FZ?U=86Y M'K`)VZS&,->E%WPMK#S,-8#-V]TK#W.]8+.X615BK@ML4C>K2,QU@J4\Q5Z@7QKU.>F"O8CXF!O%PQUZ,?$X,.U8JY8KV8 M)30+&7/PO9@@B*L;05COF>O1B'B`N@5Y<.IG? M`(7-Z^*RRAQ[+PB\47*98^\%-QN67>8Z]8*G]?67N3I]8F=1/6:N1Y^(6E2? MF>O1*[86U&OF>O2)K47UF[D>?:)LQ?[INS[1=SN7!`^$@$WDK1+0'#9L#E<5 MAN8:P&9R7:EHK@5L[EZI)\TAP^9G6:5ICAXV*\MJ4'/TL+E87)^:8X?-OXT2 MUAPT;+*5E[;F^&&3K+#N-8_6@\VL1D6PN2JPV7:E4C:'#)M>F[6T.6KX=+K$ M"IM'3:IPMX\ M"ATV+QN6]N;*P&9FLS+?7!?8E-VJ`\YAP^9L575PKD$_F%Q>+9SK`9O'A6E2 M.738["U+FX8?-QNW;Y(ID*;!)N%S=?`(=-N.WJ MYPO@L-FU71Y]`1PVO[;KIR^`PZ;5=H'U!?#^\&A5@7T!O#\L6I5H7P#O#X%6 M-=P7P/M#G%61]P7P_C!G505^D<6K/\Q9E8E?`.\/P7P/O#G%6Q^P7P_C`G!5YC3N!IO!IEG6O, M"3R55P-XC3F!I_!J`*\Q)_!$7@W@->8$GKZK`;S&G,#3=S6`UY@3>/*N!O`: M(TY@6?C6@4^JC$G\*1;_)Q%<7_/!YYN MBZL@O<3G`T^SQ16H2C5>$G;21<)NE1D7JL)FWZ6JY5T/7H#R+"W*;,LD/$F6 MI39J6L&F9G;YXRIEATN5V+QFWP(];'[FWZ2IQ':NIC:U"YQ'95:HVMP0>)JN$O19>DS" MV9A!HI-#E@&%ITRY"AY)_;O`IO/F=_F9)>2IN.0+RV5%%XNKK@LVLS?5*:_D MQ>0^2(JKE'X9GK"OIA!L?F\J=)Z04> MXPJ5PV^91,T'GJ:K->3D=UE]X.FYFJHL-ENJ%;\X3(*OC3MO`0!/Y27M#-%W M[==40KX#!3Q[EZ`>>JL4'O`<7B(5!/7P@*?Q$FC16*T!S]\E4*"18L8'GKY+ MID'MP`UX$B^)!O7S?."IO`0:7$8E/I%-P^;N504:E@P\;]]X[)))C%1>[M[%0_"]JMZ$Z7C20IDW)7 M?UW1_N'AX?64%'$T(:_'Z72WU)R58J!KSEE&EEH>DR*(8CJW"#['95V<_"LI M=J\(RPA7I,F/6?I0W"XR?"WZ(BK8R_;H__D''E.#/YG^!WOX;O5TKWJ\QY[O M_<'?\"<56GF+5[W&6[YGY?O3Q?&*YO2_@R)=?+O;C$Q6/WM.QJ]OTOO=D$2[ M[)XD^\<.^\?.GK^S[[]^S,._TC_]=IR.9PQ1;1^%_^GP,>9C8F0L_M"JT*@%5E634TLZPY,E`L``00E#@``!#D!``#EG5M3Y#B6Q]\W8K^#EGV9 MB8`"0]WHZ/($EV*'6`IJ@=Z>B8Z-#I,IP%.9-F,[*?CV*\G.]$TWVT>7ZNE^ M*-(^UI'/_R=9/I;EG__RLER@9YSE<9I\V@K>[&TAG,S2>9P\?-I:Y3M1/HOC MK;^$__YO/__'SL[?CJ\OT#R=K98X*=`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`1NA6R>'Z%Z(_76C, M.]%:75$P3>OZ%6=Q.O^UDDN(R6G;EY)N,Q4+F$(8*KH>P_HWH!A+_^-7[DH]&RFL2!P"0E#UT58;4!L"R*;W/$@./TN M$)*@FR+BB/1(<]HKG2VBAXZ`G7UC">"Z@%&^772X^8GH;Q=R<\^UEED84>/R MGN)\EL5/-"\@4KEE,EELCD-@S9L>&M(W-CLE@!,`#@B"H)OBX3:+:';KYG5Y MERXZ`G;VC26`ZP)&^G;18?43E;]=B,T]UUIE841-WP*:B'_^O-S@?_O`CTQ_ZBJ)L&XO/]/9X5\3.6$-&QF8H$UR4L$VT7 M-12;[^4W4CN.A.B9S5`Z7?Z&\G!&D&I#]4TI#&-$NGZ3**NVF4[LZII+2=P()1 ME=T8-[E$H'VF?<7[$34S*L89(XO4]PN.\E6&.1V$R&CT*%GJ%&BTS/<1-K:C M:H?##D$>B<9`6JF`)3JXO8#8#(X0$SV#T$MXC,D.C&ZC%^RDEU"=OXP,2SW' MT7V!,Q:@J^24/M&+[U;T^I0?)?.;:('S+WAYA[..O-I'C4[%#ZL64'9>TVG( M#$NL$$W?-6U1E,P1LW:2P1\6MT92?[BB=GDX0I[UK MVK00$T.95LF5NNYF?H@&*Z(H3LL&[Y'_]H/#MWOW0N3.`(*!/9+3VL MMZ#?RFUNTEZ"TV[DO(R%>%BZ5S_7V'<3?L'%[BVFKT,4Y$KY7UGZO7A$7].L MN$\7CB`+OL:A8`2.$U.ZX@YS^[M$=B,`1T*6R M6WJ3`#?C'M$)-SH'27`GC7].:*_S_F#O7<`=__1WCQ55Y`A&U%[I8;W%Z?A' M=-JUM.9";&C\PW$3EMWGT;:WU]_A.D`-AWKE&AH.]I]H>%#;+@?;+BI&MRQ_PU.7P?H?G!3KN%^ ML.'G#RF+X7[P4-X/'H(UTD.C_>!AKQ\\]*,?/%0*#1YBT_W@8;?'M@Y+E`K_3ZOMCM<=7OK][K/`B1S"Z]TH/ M-UO0V$V47NP: ME`*.FPT0FWW..P=E3'J@R!4Q-Q?E,5V0^YTSC/.3B+=,D\AHTKP4H5/`V2E] M'V%C.Z([4+6GQ,7-U$YI.#IS5Z0RV$"$K1$L7/%!;@L$#+\*1KCIN.KC\QNS M\($;?E2$^(BU,3.(?<*T;TL>JKY.T-6(S48/7Q6.@<:N(B_A9@]:[_*@RU$% MI3%JU1#$S)MD2;**%F>K9-ZK@K0+&G#(`Z+#3 M&AR[QEMH8Y0U.=(^2],B20OB7C[2YME-'&F+78..M#EN-B/MS3Y?1MKBF/1& MVG)%3#*3G^)[G&5X?D(NQP]*="3F$PE25@04)+&W<-,KK4U09>,+5\I(]?#2 M4LTH9==$#7QU__EE]DC_8@,^!6GR0Z;2IE,A6.*D'FOJF!E*[]':<#VN]X,] MG;CU^=/5TB2#GU\B^D!8FG/LVDRDC.\2%*N.B\W5L-KN14*2'X8>)>+@6\#B M^/7O.,ITX.A8PB#"=6\"E+:C'BYWKXCN]PD;;FA$\`C%L8"0;J);8@X#DZ6T MM]A;#ROOLN#*2(D`US7JJ;0^R5QH1DO=7 MMG)8;=^_QL7C-9[C)7,N36(-.1"&,YW*F7Q6'`EUKM2IHY+HK]]QG]3)MDNKM)5DKH,++L[;HEN'5OVQ+ MCH)'UMKE7.Q4`>HV.G[U]$JO#*0.I2Y'`,UZ#+C^RPZ#1]3>M5_B5=6;>G/= M5T=.!TJGUWS=QU@2Z>>%45.%FD>9P\Z#'6 M-X8A3%0)$WSU?/7HJBP\8TL4(Q%9,JW,K+"V?J_L=I4EZ3,69)'%9J-76%,X MAJ%(Z"6L7ZA;[W*;-U;%H['6FH86=E@1]3\R0S!>#/4[$C]<9AQW-^JP2,"Q M.#6Z('>S^.&5W[OT]HZ>V\IW`S2;M5-XN-[@MN,0G'-CKJHXND:U5J:\9(93 M"3"=SI+XJ;GP)TVE#DN?%PL/C5;9"7MHV]KMUZ4=O]&]K2=[-M=074 ME[(;$!E-4=ET\Q?X*+7WI]G+0]%FPE%S5R9,1$93\#"='!'X*/'P)P\B#T4; M#PG@FTQ!PVQ6@^NAQ,*7!(8L"&TDK"7)^6UR-:%9^U/.KE!9#15>I,3%P0^FB"XFY$@ M#T"?!LNS#=9NE;?-,L.I<)B^?9;X:4#BSWVT.BY];AS<3Z]=*^ZIQ693N3%[ M;RWTTF#&EYML543ZO-B?&:!UAPU^6VWE7EIX`]V_9:YV.;ZMD=\E>W!KS/P. MN3\6'@`%CL4[99$_#DX;*Q^`&GBSK"&9%[CU.90B)F]KU-ZX^#ERWV>;J3$ MG%F_[^LL;7ETEQ=9-"LZ(`BM@)8E[;H%FK4G<-);BO0G#]8@[89`N/HH+_A6 M%CA.%ZMEZY-@)(PPUGL6.VTZ.UCGLQ$2]WS%7$T)C\)5ZN MEB>KY6K![AMOH@6I`%O+[>H99U?W]S@C'=S7+.Y)/_#8\:/T$56$&JX/<1U6 MYJBV1^R`:I4_]*#F&'\D!FZ`+AY[ M7^;3/,88P,TJ60*7N1P,K)]X-L,W`,NNJ"9Q;/@^7SZE.9Y?)5\),(]1CG/- M?G9H&1-Q'5=E4'P'5F&#+W;X0$/O MR(G8#ZD>*.Q:CC>(;Q80_H$&&$-"VX-YJ/@N$!8/+>1'&$+6V+!"ZG`@HCX" M*1U0Z$II:3AQE5SC.'G&>8'GI_%S/,?)/#]*R-]YD<5W*[KD2JZ@ MT,%6:CGZC2:U>Z`7FR2.PL9:4V0O=Q!QM$Q72<%6I<)+/'>"IT:P&B]`699+ M\_OPAZ5@"7Z(2`.XF*(;_53\OYARXL_(F^\<9-T!$%$&FWP7%><4*'0'BJB- M5MEOA[X'UW(S:GR90WJ%E=B-7Q%-X1JFJ8G=A,TOK7C;/RO#U%P/34,DTQB) MP0%!Q1@<;1P<*RW5UM:-[-%L1O&O:#K*]`[2ZZCS4UC MM5?<1S![E_>$LD#U;O=44MD!2H41(#R&D>&"X@4,&@A8GO7"RW)Q+6!FNAC( M1?$<=&>W;".VW?VL%D'>1Q%Q.U]=%DR-D]B!?7?9S/0XL1O.EY>=3)%3!D+R ML65KT^3ZGWD639236L)]I-O09#F9(^ZGNEU/F-.(C.QCW38GS25D9+;$[`*7 M2T:N(K/Q(P^Y8Z@!B,!+6.\IYUAZ-UB5AZ(:# M_;M`BI+^86/1&EHQ&-2TO89-2_8`K;)%?R+6.\&?&9`NH!L:N!K",:(:A_(J MNXF7\2+*+M-D$):J`R'`U*L_/B$ZNMKA-&3 M=/F4)J3##MCMQ/JJ+T13PWXLD=I5@0%1[2ZL3J*L!X"=W5>.W[A).6&92&EI0@:-D!2`A-FU69/>B;G)ANOC8DD5S,D0E3)$6T>)B MK#IT4H3[MCQ5`LL3)8YF_US%&9Z?K9(Y>W$XF2O;M.8Q8U$:5"68]J[G,ER; M(6I79J-H5L`E;H."5<,W6$*37S`4DP:)E6F&>,#H7"@-=%RX+5\)2#?P:Q336?#9-8Z7=ZLL9\EJ8>/4.6`L,/J5@6F\&OY" M.E.F-*+IMI:9"ZCT0U1#YE8R0S-CM1S_:ZAGN_K4U+:KL]?OT[CC+AS"25,0PCHDJ88*7GJ\O,-CI^1=1F MV_U,);TPB9"R)=?`[A^3(8SV?9W895C^^O%E<7I-H%79"Z2M?FT"`T_;H8D6 M7GGHM^OO)ME'`VKE[@MHQ$7%C0@<+37?C*/P1P^V^<1ZH&^[]3-\QTH%>^,-\]W.LWS MG5>XO-/"!5@(6\V3.@I_R'@[;Y[!GK)Y!GN05-0.335/XD%G:+OG$R]U5&2\ M0"MAJ7TR1^&/&7"G#?0RK8G5RDWR#X!!1E89$TV9ZZ_?L"_31K/V()TI"Y,( M-95LEE$;E/*4'PB/GLU4J-2O`D5_LZ0ZT=0AU87:%JY8"O?>9%5-R>C-%4\C M\\HSAX?0?$:6XTW9O?B2+!1'2H<^TZI9[C#\R^5"R.-7ER#/]_+,#<%E-`_, M\:;L$KS)4(I#I0V=0=E<]`E^99`A]/&K4Y!GF7GFAN@RFGWF>%-V"M[D1<6A MTH;.H&PN.@6_\M80^GC5*2ARVSQS,W29S7ESO*EO'KQ)QHICI4N=2=T<]`J^ M9:D*#_I["0%+CW[ M&A-ES,V\S9LDJVAQC8M5EIQ$O`7/N1:CW]05NP-Z+Y?C("PWHG(KJC8[3#E+ MHM!XX=9PW(WTWGP_8?7GCQ1KVV_5-VL@>K@D,@*APM!#(X&/=IOTX#&0/!8" M5(QI8+YQ>O+89EK8'3;2=K,A_=T0H#0=P3=85GIGL$NWN2:B>=9\ M$+H1MJ%X]^%Y?S>0XL`/QWNE]Q4//%"<\R15%F$;BN_+%=\'4WS0%6"PXOL< MQ?<]4'Q?J?B^;<6[3\/[NX$4!W[:W2N]K_B!!XIS'HS*(FQ#\;=RQ=^"*?[6 MJ.)O.8J_]4#QMTK%W]I6O/MPN[\;2''@A]>]TON*O_-`<S#%WQM5_#U'\?<>*/Y>J?A[VXI_D"O^`4SQ#T85_\!1_(,'BG]0*O[!MN(? MY8I_!%/\HU'%/W(4_^B!XA^5BG^TK?BA7/%#,,4/C2I^R%'\T`/%#Y6*'UI5 MG)R&+.=6[H90O.D(7G%6>D=QNLVUXLVSYBO>C;`-Q64YMW(WD.(&SDWNLT#Q14YMVZ$;2@NR[F5NX$4-YAS8Z7W%7>>M5!QNSDWXE"6 M)V=9" MQ>WFW(A#6RG%NY&TAQ@SDW5GI? M<>J7W%`\\R+GQ7O^21=B&XO*<6P"6#DW`(/#DW`(/#DW`(/#DW`(/V#Y9SVS>:<]OGY-SV/<-.O8&DEJ>5H#M3N@9"0.`JKG:A%B9,EES3BT8!%3Q%;W%PT M3T<,364&2$S+L3%<2B\A^\<3-%HG+N6B%W1;4'"7>Y?8`6)A8H%WL1N'2X,K MSUV*1C_R5MGH98?$=M!L0.>+A&Y^8CM@.,`?`PO= M.%T45'GV2CIL/!?N>[Z)R2EM5N%14]*U!Z2%7Q5CU'3QWO:B5)Q#Q@R*% M22R1+:BD*Z,IS0&1,KE.FLJ;#XMR:49$BI-0'2,T7,'6PJ5+ M0AZ3\K]U=%<9CR5)KQ(P'"E\A73_;I5N*2W0;\S&R1J9>I&I>=)7R`A-9QC_ M&L6$Z:OL&L?+NU66XR5.BBNRZ2C/<9%3J*_N;W&VC).(A M^BBT/@S]5A[H!ZN:L940/(`#L]]&FCT21?%M%LWQ_&R5S$_2Y3+.33E-8IA?XR="!VD& MQVGQ^"7*"S*,3.9DE#G'&1]#Q2$3,=2J$"B&I>Q_4.&8OJD`K!,*KE,616:&VVC8@ANX9O(V:+"*H;:X=@#@E? M3>102)U'VNJD=QO2QT&)%!LR"T<"( MC"-&![\_JIB$CN&;M+P@ MK7%^FU[C^P6>%2=DN(-%.2^)^?2;,WE%H&_,!-Z:-V6E"2KHAY29$:JL/(!3 M%2[>O9A:.J.H7:;%24I<+JI:T$'VZ0K?IMV+AH"]`<=/A7%P56'IU'=?XTJ. M0?5!#%IZ&"+'T1^<,8A[B`>'N4_U*"B,8'Y#NO0"/[QN'HF=T``D=&O_&;S* M>"S`>I6`H57A*USO1_5SS9:%0P#UPE33IB^7L1E$%VF.OZ0)?N5,&&KLFS(_ MJ.<";CI0732;_8/H;\0V.*2`>\[MB3[IWCL-*SF(*) MP!T<(5T')1QE/U%N+LZ;PU"D>CIMUP24?U2]7ZG?.LJTR)X[FU.Q]N;XI:&/G)$U[3@!EK6]GX8IF?`(VS^S1;1NS])_87;?_GB\4J M9_>D^?]&61S=Q8NX>+VZ+]]+Z-XSC"QC]`3J*54&FF`]J@IAXS#4.`XU#D2- M(^D\B.I8AW!."G=C)O=42$SC?Y5@^D[I57:!VFA2':Q MMX#INRATKQ^P<6LXU(,'#',B2&J M+/U#CQ\\)8-B24W#^#7*B].4/6@EO6I,2L=G*S+XD_1PDD,`4%16")Q$L<<6 MB-0,4;LJPUA:HM+4#Q*5L>."J*6G$0Z/H^SD,>H\3,$+-S")UNP&K@AHAG%+9K'.5ISP_ M641Y?AK?WV,Z6>J,G-SYO&9Z1OY,'TEKBM/O\#:+`J?(U2_,G4O/>K(>!QTYO-`.J"-T^=%RWFT*9@217ZZH9T*M! M=12*$U0?YP7T`T++XWL@`$90IMFLVY2NAB)>W59@,Q9-J4L8!/DN0I9Y+-)R MJ9MRSS9B^UQP)(U#S8LR^D:[N*YWSIIQ(3O\J-CQB1I]8HS3\M?XX1'GQ?^LB'.<+5[%UR6IY5AF M--S#8"-S%%8[T6:O^\N51F!J>FQ+\_N@3UV2HW-\,44AXL_=$OE02M"@I=D< M9Y^V]M^87]]XW:/P:R096,@.F'II4%<&]B(A\2=I]*X'&>HH]2\<>JHY(&T0 M9:8(LTF7F"S_F!K*DW&6+M+O>J,1F>%8AM3.8?B1^`G+?3Z-1-11J>FQJXJ1 M88C4G;M1"(P*CL8@W`I)AB`2^ZG7!V558"\18G?BENYZ^*$,4?]JH268?<2& MX&4(+8M8"9'R#J:!(-FXOEJ1N=!GZ497?-DO4C*;?326U5'[Y"QU`VI$`QW M6A[#$K#+%&WLV'-S:KG=6)"/63M\6CXD?#6(0R6UTOG]0E<\*[,09W39WVC! M^X2'YD%0G:"\4F8Z0H%/3F?X"ULHK\H^5;;N/@0R*'3B7E$MJ14D<6'02&IJI@9*(5>.5B6DTQ+8_I4EIBCM;T/9*HB*&93 M1UTK=%XEF,UKNKH_NB=W3J0J-X_I]^X-L/914&PJJF4&39%3#IGT!!D]GY,O-<)HYA/#8&MX-E8''U=$=:E=S_G,.`X*$2553,#J=@M!]/F M$OHUI:6]#WPJ8R@F5$MA*XR>I6F1I`6][Z=3H?FOM:_GCXZ;UV_')53+,!D0 M,XW*2(TY[7'C9_,^@6@!B'IN]8_QBH%-!L2=@NEV8>O;S_QEK62&@-][-K+H ME<1/Z'#Y*_7I2S_K;&MQ+)YKT5I9"EM(4`RMI"5W%99_^T*+9&TM;26,,--8 M#O(&/^/D-'K]>XP7RXUF-6#(43D+6PM[,A-$;!`SVEZOP^?P,JH9 MK9JQ`;K9I4S4/>D<`,Z:H8Y*PY^4./?+`^I'3`,Y]WT;;R$(CL`R=GQB1I]8%RPQLKA MJM1RLOJFAZ8R1TTN?!F$:@2&PXQ8FNH<+LB!Y#?Y1?ZXBW),?OP_4$L#!!0` M```(`(U2*T*8@P!^FA\``*V-`@`6`!P`;6ES=#8M,C`Q,C$R,C!?<')E+GAM M;%54"0`#NBWP4+HM\%!U>`L``00E#@``!#D!``#MG5U3Y#B6AN\W8O]#;NWM M4N!,/B>Z=X*"JFEBJX`%>GLF-C8Z3*8`3SEMQG92$!W]WU>R4[93EHZ<17)\ MU*.9BZ+3Q];K1_[0*QU+/_SY>1Z/GEB61VGRX[O@__^_)__^B\__-O6UE\_7'T>S=+I8LZ28C3-6%BPV>CV971U-3I-DX3% M,7L9G7T976;IE.5YFHWVW^^(_X\6.3_DZ-/B[U&1+T9G2<'++,)[-OKK+V$R MV]H2)<11\O4VS-F(BTKR']\]%,7CG[:WOWW[]O[Y-HO?I]G]]GAG9[(M`]]5 MD7\26R,@/DIX6_/5VSY"[-YF'!JX:K$:+^5+P\LA_?Y='\,6;RMX>,W?WX;A[EQ?[6>"<8!^/Q MSOOG?/;O_0Z\_0K)5U'^]8H5BRRY7CQR2>*WGY,XO&4QFWUAQ0T30HLT^4N6 M?BL>+M.LN$OC*'W5Z7Q_H9LZU?D\S%[:16Z_^8EVBMSL68K+>+:(V?5#F+&' M-)ZQ[!-C^<9/S5S.VYS/<9(LPOC3(IE=/+*,7_')_(2AGZVQ\+>\AF_2(HRKIP%X MZ7X(LQ-^2.$-P>Z)2-4;[^RW_J]P4C9[+E@R8S-9NI"\P79I M5(C#[93_&VV-Y#[M/_G^H^H`H_812NUH+LZD\%/^S M4[FK=F@9L?W(&V%)L35]B.+ZNKC+TKD&S+*L5"\QS7A#CMO''>$?7\]PQJ(* M(O]#I4C?\L`K`U4U#H#/7L:"WJF\@;I@2Z2X2TF->JS-1LY_B\%Y! MJ6RCAU`1N$2WAXWNE.73+'ILOZ)5@BLAA$&NZ%SRW$?BR=O_HB?T^F5^F\8* M2&4;/8**P"6Z`^1WS<>[.]Z.B)X8\*Y18NBA-`A=(CU"?==6W:8Y*V,)/%*^8Q"S]4`)H`=*>>A_ZJ=)W]=GJR-4_G3\'.6&-ZDQFMBC MQJIWH'ZOTW0>1JHA5C<.P;+GY=!F*^5N&"5\&[&LU)=,V1<6B@$6S<5J"B)V MC9ID;KC_<$V>VBO4'#8(4_`BT*-5+E84N,=W!67R2GPF9&MPN!)S]. M9M=A+)(QYK`H>84X5B_Z9W8?QE4WB^8AW=E* M[.GZQI6%W5'ZBI$RX[U_(FZ?_+J*ET9'<-[#EA1[QZ"J)O-U%$W M2E=ZUBFA/H)1'SF#^DA!?40-]9Z^\=#=3!WU7KA6PAOBZ0PVC,E:_@ODE*AY: MW\%`M;'.CO2J8QWULCY0;@[@JZ3^M0'M1KTN(.VRPPAE8$1^`@5R-P71HVQ2 M*JWYIM(O^PZ.@%B!.'ID`;&R_8)RP7X)LZ^L*%.\^W+NMPL]Y/UT2_HH0U.- MX)]8F:-K;('7V^EQU8B434.42_CB]N]5+JZ>87^V5C4'__JQOI@505 M2G8H/1C+PL_#3!C,)YM9T,61):H3*^&B-%V5'I234/J.8P>6;-6V2V`\H+J MR#!Z6"#0`;J:;A?,E]BG-"V2M&"YY26FBZ-'%Q`K>Q=1_)5\*)TN1[)$C]"] ME3$03A8UH%D21_%C4LY5F-RSB[N/S],'\5'#R]]8:&A:@)'4X2IR)6+,%Z`<#NEIYH!PZK`!:S=& ML7:ZNM<[$3"2.F=%KD2,XO3,8WSK7N"67:E7@DV_K!44EVB6UO\F`/9RJ2[T M-\=D@!R,OLX'"*<.'O!!$\Q6^5+.29R*BX&4Z?=52Q9H[3!K[F\@MV_ MZ)N)G:WT:'8D2GPX_<[+TJWO22B0+E3@'3A!:9D(F>81>\*7Y8H\B0PE1TV4 M;+T<34$T04*7(4I33(BPOOE-0329`F_Y791VE1!A>;?K0VCR-+['=U'S(8^3 MF9ISI7]^]MF!'ND^JB5W[`DEK`]=2RP]VA;!$C1*0U76/'PU.W#I=JY3E'Y+ M6;KU(H4"Z4*%+D^4KGAS!Q[0>SBS.RN"+`]J M>SA]YL8']UZ[R8$TX>AKUA-LS3(Z'FV-Y*'$G\W11N)PH]]L\XK^_D>;6'2= MO&/#]_W&*&(?^1MU#OBE_TD:+^:)9N)](&X(K)8K09?5W5*,^AW7E_`YFB_F M)XOY(B[?U>4\A54JWL43RR[N[EC&'VR76315J:^Y+]&:6/,L4+\1LVHK'CK3 MN/3\UY9]QBT:VG=LT']/FVI M4687K_];M;#ZM,,)4VA>^]>)%&\@M#X1+259]?&(K2#>X7 MAO(+0PV'RR\,Y1>&\@M##8?:+PQE98VRWSWQJR>X$X8BT]0"EFAF]W%EY3CB\8.01/;``3>?S>R%=#_%%#S=MNR+K+K M:![%87:>)FM5B6U')RK%=A*HB;DGZ?PQ3?BI!>4HKSP'8VWTB"=;"3VTHR;? MUGK&:[(WQ]-G;]:.FGA;ZYFLR=X<3Y^]63ON^A6]B+O'V4H79YW8Z3\6$7?5 MPDR6^3W)S,JZYSYDR??4CYQ=:X'N%&$`)TXJ+:_67\)(Y/-G5RR:WRZRO'09 M1KQ]=B"+NX]XU(S<8X^S]'G.?H\1Y_GZ/,<,='[ M/$=RY'V>H\]S]'F./L_QE4T%G^?X!E1]GJ//<_1YCC[/T>IN1&6_`@+@:\((RKE@Z5W[@J1DC9"4#*,L0%ME(K:D*C1L+$3G3B M$-$)G>B>0T3WD),)NQ*"'2O18,<=HD+KIE,$_?"P'Q[VP\-^>-@/ M#_OA84ST?GB8''D_/.R'A_WPL!\>WE1/IA\>]L/#?GC8#P_[X6$_/.R'AX=^ M@/PQAX?/TV9UA>\?*MX#AXK_8W2>CIIB_,AQ[S[X=NWT&D76[T"L1=A'\G"C MRVT]:XTTPSL./T8"74QPM9`:C6X+ZS$RK0MWN2X(C%YWY,`CV;IPYVM@V-'N MCAQXY%L7[GP-##LZKLJQC)3KPEVO`3^:[D?3_6BZ'TWWH^E^--V/IF/6A!]- M]Z/I?C3=CZ;[T70_FNY'T_UHNA]-]Z/I?C3=CZ;[T73TT?1JZ9>;M`CC*U8L ML@1<2^9#F)UP-DTG:VL,?5^[IDQYY-'RT"/;6/GH?V4)__=/-6HNS[HLS3!0 M;H@AUKXSJ,0<#J^NO.J2.PG+[GZUJT$7,01(L-[+W@6=4M3!ZQ4%ID0"4Q!] MIIJ<`)Q>RI:(LV3*RJH]#0N(K!)''JZB%W6\N:TC.#I21S>[F\G3K&2B#ADK MQ:N)*MW-+D`,-C_JNP[$,0QQ[`;$,?)Z*4KQ:L).=[,+$%LY."@+GRC%[\(0 M=]V`N(N]OLEJ\6KB4G>S"Q!;N4@HBY,HQ>_#$/?=@+B/O"2)4OP!#/'`#8@' MR`N+*,4?PA`/W8!XN/E51-:!>`1#/'(#XE$#$=VQ\%."'$NUF3S$2J:$B.Y8 M>/&08ZDVNP"Q<2QC=,?"BX<<2[79!8B-8QFC.Q9Q2C!$%QQ+)5-"1',BQ5)M=@-@XE@FZ8^'%0XZEVNP"Q,:Q3`9P+)TOR+J;'8#8 M^BAL,H!C"6#'$KCA6(+&L4P&<"P![%@"-QQ+T#B6R0".)8`=2^"&8PD:QS(9 MP+$$L&,)W'`L0>-8)@,XE@!V+($;CB5H',MD`,<2P(XE<,.Q!(UCV1W`L02P M8PG<<"Q!XUAV!W`L`>Q8`C<<2]`XEMT!'$L`.Y;`#<<2-(YE=P#',H8=R]@- MQS)N',LNUD>F?AH+/XU%BZ6?QL)/8^&GL=CPJ\I/8^&GL2!`WD]CX:>Q\--8 M^&DL7ME4\--8O`%5/XV%G\;"3V/AI['PTUCX:2R^[P'RAYG&@FL([S6S67S_ MFA`'RGP650GZ>2W\BA"`?6Y7307,,,,%&$FL`0AJ19WMHBMD>2/:V*K/1D2P M/:X)`^2E:-PI,+HRM`LW`'%N01YDC0:3CD[VASG.0KLZKB.DBFK9T2QTU;CW:*NJL>=<:.K!YQBQQKN%GO#M#N;RB'U MN0$^-\#G!OC<`)\;X',#,-'[W`!RY'UN@,\-\+D!/C=@4]W5/C?`YP;XW`"? M&^!S`WQN@,\-&/H!XGIN@.Q.NHKRKU7/Z"DKPBC^.2GK9/V,@,/1UD@>E/\I MCKM='7A4'7GT6WWLWZUK7?S1D@!\O[#O%_;]PKY?V/<+^WYA$KV3OE_8]PO[ M?F'?+^S[A7V_,(4;W/<+^WYA`MTZOE_8]PO[?F'?+TRO7_C-WGE-#[#ARR-= M`+'6@TXBYG=&:B]Z*?"&/1L^.,(:QXCR:9P* M`ZZ*/`V+\&/,1-\HN&RW;C#C2`QFU$?6#V>(XX]^DR7X(0T_I.&'-/R0!J5K MU`]I^"$-/Z3AAS3\D`;%I[,?TO!#&GY(PP]I^"$-/Z3AAS3\D(8?TO!#&A11 M^R&-/\*0AKFQNWA\K/JP3>,5V@AZ@Q1:F:O31SEQR?[$PEF4W!NOV'H[O2K0 MB$2=6>KB]N_\9HJ>F)YA=S,]A%V-J+-#U<5?9M$\S%Y,SP0@CC#3KMA-S__4 M#^XUFZ;)K`]>721AP#JY$C'*"J,?GQ]9DAON?W4C/9"J0LD.96'19>'G89:% MHC)-%R<01Y:H3JR$B[+@:-G.?DAC7N0GQO*34#?3H2F('E:3TGKT:PBF:;R8 M)^?A7$U^`.+HDVV)E7!1!L*_A,_1?#$_6W;!F\87=[PI MS1]2_)TZ58&ON2^]2ECS!&3%H`SZ6K45#YU>AY[[.%@1E7!9`2ACO4M-+25G M\W)V^XOD\4YR1I%,;U7;,;F90.49@)#VDH%R)&-.@-DIL8)W`V4!$,9FKW4"ZAI_+K`;1&PR\ MK$QA].":M4JR**ZI;=W$IR,L>XJF+!C?!B#I_KO1(]]?NZP)%'/5EG6174?S M*`ZS\S19JRYL.]*N#9MZ61\HGNTDG3^F"3^GH'Q=RV>@L1IZQ-.CWT-TG::/ M"GV\)G1S/&'H9M$2.HH;K/5,UH1NCB<,W2Q:0D?QA_U0.P38BA7G$]3I/Q91 MQF:?%LE,O#[X"]X*N><^])#W%"XK`,5G6FF[@1;BB.(J>7W^$D9B+"6[8M'\ M=I'EI5LP97S7:3[Z393Y4E5UC8PR$DT4-:);$46RAE',EQMLO[EHC[U;J\"YTR<.Z M)7U,3_@A8^'7QS1*"C&KI!A1-GA#;2!9TEJUDB^*5^P(^1(E8MS^K,S5*QR]"VZ)7W,+RIS_F\< M5K[VXNX\33(V760B]=Z8([76GG3KHI=\624H=G2EK_ZP_%[E8UY$ M<^XWP)$(XR[T*J&?[GH2K8''*"R5L-:>].IB+?FR2C#M;KYRM?P4<3*R\E#M]!5OZ?%K9W:37K&[F$V+ M$_Z89:;F+A!.MRK,FB5Q5#M]GA8G*1<0+S4)4*<+=I.J=[JA"M;8GVZ=K'$2 MLI(P7??'YU`LQ@!.!J+&D(6M"I5`,6WV4L.'E[^QT#!"`D92AZO(E8AQ?7*I MI.\D+$`X==C`E"S[F-YXI>[UGP:`D=0Y*W(E8DP#O%0B=.P$(%L90AVJU"EI M(GU+V9$PL=.<.$)STIJA>"":>W::>X[0W&MH8MK(EH1@QTHSV'&#IM`I:6+Z M.OFF3)LOC-=M&%AVI4[?IE_6"J;WTTCKWW@`]G*I+O2-BH,!W%U;58\&AB[< M)?!*P^-@`/O7D0,W0G3ASA%O-4Z&<(.J'+BAH@MWCGBK`3.`&U3E6!HSNG#7 MB+<;.0.8P[[Y=D`X=>)`]MW!``;R)$[S*+GOQ[L;3)UV5W&]*@O*!!Y<7L'N M7_3=I)VM]&AV)$I\*'Y2EF[U.U`@7:B`ESE$<9A22)UQ?9(F4WY*F>XS%%LP M7A!^!*S(D\A0/)XHV7KKFX)H@H1N>107)T186UFF()I, M@1;5(8I/$R(L[2A]"$V>YC83SD2F7,+G-&=?TH2]:#"VMM'DUQ(HP>%,3RJ> M+VDR$]]8YM%=Q&;7G,A"33XQA]'$J==M/`(S?!HB%'EU-!!\38?PDQ\$UH< M)[-+EMVEV3SDWK1<`%3O$OOL0(]L']62.XK_::FP6DM++#W:%L$2-(HI:FDY M2\J_!)ZS.%[D9;=,_C]A%H6W41P5+Q=WU3FI3=7O/`;IBEGG1&2%H?BNEL:+ MI,QXN<@^LQRH$R6,-'9%JR2+,Z],(^-X-HL$EC"N6N!GR8P]FPD;PDF3-FB6 MQ''FFVG)>0JC>'EK73YP[P/0[H;2)MW5VZS./B#F7]CM=52("R$#GQ_0/LZ` M5X77-8#BZ5JB+L.\.$W+[W'X+1?QH[-/"WXRP`4/[$*:/Z"[QH_B#V7S%FZR M.]`^[RPVO(/B$67QUJ8X%$B7*K3@\`ZJS5S>+=B<,!.)HHU7$UG11S%Y;2,#=#@"UVDR;9:6Q1HCBWI3RU5S^[F;R M")M<_2#`F6-EM?PQC'#L`,)Q"R&*M5+*5[]OZ&XFCW#20HABCY3R=V&$NPX@ MW&TAQ%G08;5\]9N/[F;R"/=:"%$\D%+^/HQPWP&$^RV$Z)Z&EW\`(SQP`.%! M"R&ZE>'E'\((#QU`>-A"B&Y<>/E',,(C!Q`>M1"BNQ-^0I`[J3;31EAIK!&B MNQ->/N1.JLWD$;;Q.`@?<2=!R)Y,!W$D`NY/``7<2 MM-S)9`!W$L#N)'#`G00M=S(9P)T$L#L)''`G03 M`=Q)`+N3P`%W$K3*[BDN6 M1:DZ9\@F#DBWNEYS5G7%HG[$4YU3_BG-2K7G:7%1ZIV=)9=9FC_R$^E,IK/F MOI2KJ]<)U#6#8N#$%[LWJ2!6C2?^'0^GQ MA?76F%$\GTE+3\0NX6VA1?&"/T7W#RPO_GO!M;`L?C$_&H!!N35C%+-8 M?Q6JE00\*Z`=Z!'OH[H&CV(Q845K07`LVBAG]G'[K]R"!`NE!AM1*P'NH M9E2K"'B*`/'TL0=XYVBS2*<>PW<9M#L[79IF@+]E!LGRI# M?-EOF[F@YS[TF1N$US6`8A-54:V9G/CME]QW%G[OLP-]]CK5-7@4XUB6?9Z> MLMEB*O!\2C.Q=+9<:_LF?.XL)MYO%WKP^^FN\6-/6EA>$#]S(E705WE="2CN4U553NH2LZA7A%%Z70_8\QF6LOA#,@Z3 M"M=25WG?9I::`/:C7Q>`>%D;^]C3'E9WZQH3"1MWH,\?FLUL'WNVPU)1/=Y> M#3;J9]F50UK?-TB+4R3]RG^;\ZXOGT'\NC4+I<\.#E6=[KX=Q-!;LE/LX?2A MF[-5]G$2=Y]X\_V>]9B,$`BDAQE26P/&2>O5*#'.4`C'NH%9,U_A/D[V;U>, M;I3&'.8$7V6$9A\G*[BK0ZXM;V,KXYR`*\76='$2A@U".A^BF.//E;Q.*9OK5LC:8'W"JYYHWB!8UR3(WG M/CLX1%W3C#Y`<80F1;I%<2RQ[N!6EL4Y0+&&)C$](;O$MX46Q0MJ=-R$SQ__ ML8B>PIB?64_.NGV<@*X37M<`BF6\>8BRX@5^2QIBZ!$V"*V)HMA$183I/6@. M(\]5]\Y#\8BK.G1O.FT$=:#*6^T0Q1&N2@`QTB?8@H=B[.K2K6\K,)(P5NC- M=+@I)S=C4069_Z%2YC_]^C$IHN+EBMU'0FE2:!ZC^A!Z8/4ZFU5$,(;MZ@\_ M-7T/ZD9Z!%6%S1S'#;L?MMMR/_-=JY_57U?.@CT7+)DU"6@KYZ'B+4^A$7K* MBC"*N:"PEAH58O>=W1W^O]'6Z#3*IW&:+S+&_T/LN%WM.:IV'8E]1[]]C-F< M"\Q_?_>VUX`9<6M-=S7`W^@;N]']??Z]]SG6.^$$```E(P`` M$@`<`&UI`L``00E#@`` M!#D!``#M6=MNXS80?2_0?V#UO+(LY]*U86?1W(H`239PLFB`HEC0TMAA0Y$J M224.@OQ[A[KX*M_D%!N@3AXLBS/GG-$9DY+8_C*,.'D"I9D4'<>OU1T"(I`A M$X..DVB7ZH`QY\O1SS^U?W'=^^/N)0EED$0@#`D44`,AZ;V0;I><2B&`?(W,SHA%\(@IZ$#(/=_4!&ZKF70P0-$E!BJ M!F"N:00ZI@%TG`=CXI;G/3\_UR(PG/6A%LC(:]3]AM]H6,D_=7E;4J;32\=+4+G(H<]Q0LA>YX=[E$-(V0<94OBF<`K*()1O$`'DJ@\(33*,R\Q M>!CD8A0H%CAXS0EI4R&DH08;(/UNS\0Q$WV9?\435EFKD->%/DG+:EG`CJ-9 M%',K(CWWH*#?<=)+Z!:7ZGNLH(8:BQC##,?$&P4:74NIR24.Z$^$\E&4DAR6 M5&^'O7@"XG*LKX"@*IA#F7,'060,RC#0$Q9X[U=]0'E)]2>4!PG?IOA@C/!A M:P^A7U([_DB98%N4'HX`/FSEG/9**K^D/>`5B^8V][^MU^+<887$'GSK7BR< M!5-!I_E*4'SB1'XFL-"7"YP]5)1VID-8B(:O$SG24J@9NWQ43_^(2PJ$R4-$ M(QD[,@L_B)AO"K.$J/9V>2/#L/698Y\S-)AWT-F^$.8SJ7>`OZX*4 M9]<"V[2`O><-$PZW#U3!@^0AJ',`O=KWQ8G5S6Z@?P6N/1Q#$XM-7E?9^[;S M=X&_O^%#`>7GB0B_XOJ/PL7@;!B#T)MXO1RDNN][T[YG-,3RD!$1*9AV75"] M"_)K>#:D]MK=*2IT+/4ZT_P:"-7]WY_V/^<@.0EY'=.\[=Q_+_>O91="O(I6 MQ_:=L!"M>E<<+.V*3^1:DC'GKDG>=:&XDX;R[#YKZ?IP3-4)KM*F;)V8P5@) ML;(A#DN7B92&Y#PK;P#)GP7?7[L66-0"3[CF#DI_]O'@*AC*^U>/B/$3U9OB\^&DQH]D]+&[E/],!ESI1,&O?*37T+'LE ML\;SQ-HXU3NA:3MA1%/>"Y:,O!9T_^M^:'N3NSWX;7HWJ,VB&*\"$:6[<8OV MH[*-O$L9I$!+4NPWM\AS[2G7;[A[?FVHP^+M]"82;(79F^W-)!1Y&TM(L30$ MM8%\\D)@Z?:@6_<18*&&TAQ[X(Z3*[`KM3%YGH*?&U.OWEU5`O>98S>!-_!T!QS&3QF4TRZ#?.]=#C;N\FV25NF.']A(+(_ M"!2<]+1A)K%R<0I(XHZ3[L&V&(8XA.*HHH'I.'W*;8\)QG%)L3LO1B5V-R@- MCK$(&=ZE7&&B\EV0\B+LC-7PF_OU*XAZH*8JF!N;DA_*B#+Q`[6?6'V'>_4# M?U[[_-C'U+[_>;'V\=@'U=Y`Q0` M```(`(U2*T+[76:![P(``-\2```6`!@```````$```"D@1@1``!M:7-T-BTR M,#$R,3(R,%]C86PN>&UL550%``.Z+?!0=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`C5(K0G6]#,,))@``R+$#`!8`&````````0```*2!5Q0``&UI`L``00E#@``!#D!``!02P$" M'@,4````"`"-4BM"OXH@3]@B``">$P(`%@`8```````!````I(&P.@``;6ES M=#8M,C`Q,C$R,C!?;&%B+GAM;%54!0`#NBWP4'5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`(U2*T*8@P!^FA\``*V-`@`6`!@```````$```"D@=A=``!M M:7-T-BTR,#$R,3(R,%]P&UL550%``.Z+?!0=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`C5(K0EB4B>7A!```)2,``!(`&````````0```*2!PGT` M`&UI XML 15 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName MET INVESTORS SERIES TRUST
Prospectus Date rr_ProspectusDate Apr. 30, 2012
Document Creation Date dei_DocumentCreationDate Dec. 20, 2012
XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 2 9 1 false 1 0 false 0 false false R1.htm 000000 - Document - Document and Entity Information Sheet http://www.metlife.com/role/DocumentDocumentandEntityInformation Document and Entity Information false false R2.htm 000010 - Document - Risk/Return Supplement {Unlabeled} - Met/Templeton Growth Portfolio Sheet http://www.metlife.com/role/DocumentRiskReturnSupplementUnlabeledMetTempletonGrowthPortfolio Risk/Return Supplement - Met/Templeton Growth Portfolio false false R3.htm 000019 - Disclosure - Risk/Return Detail Data {Elements} - Met/Templeton Growth Portfolio Sheet http://www.metlife.com/role/DisclosureRiskReturnDetailDataElementsMet/TempletonGrowthPortfolio Risk/Return Detail Data - Met/Templeton Growth Portfolio false false R4.htm 040000 - Disclosure - Risk/Return Detail Data {Elements} Sheet http://xbrl.sec.gov/rr/role/RiskReturnDetailData Risk/Return Detail Data true false All Reports Book All Reports mist6-20121220.xml mist6-20121220.xsd mist6-20121220_cal.xml mist6-20121220_def.xml mist6-20121220_lab.xml mist6-20121220_pre.xml true true